posts tagged:
lifescience
San Diego-based Ambit Biosciences, the developer of biopharmaceuticals for the treatment of cancer, inflammatory disease and other conditions, said this morning that it has named a Chief Medical Officer. The company said it has appointed At... READ MORE...
posted on Wednesday, February 8, 2012
Applied Proteomics Raises $22.5M
San Diego-based Applied Proteomics, which is developing personalized medicine applications, said today that it has raised $22.5M in a Series B funding, and moved its headquarters to San Diego. The funding came from Domain Associates, Vulcan... READ MORE...
posted on Tuesday, February 7, 2012
Cynvenio Biosystems Raises $2.0M, Gets NCI Contracts
Westlake Village-based Cynvenio Biosystems, which is developing molecular diagnostics systems for cancer, announced this morning that it has received $2.0M in financing, plus scored two Small Business Innovative Research (SBIR) contracts fr... READ MORE...
posted on Tuesday, February 7, 2012
TigerText Pounces On $8.2M
Santa Monica-based TigerText, a startup providing secure mobile messaging services for healthcare companies, announced today that it has raised $8.2M in a second round of funding. The round was led by Easton Capital and New Science Ventures... READ MORE...
posted on Thursday, February 2, 2012
Response Genetics Gets $7.8M In PIPE
Los Angeles-based Response Genetics, a developer of diagnostics test for cancer, said today that it has raised $7.8M in a private placement. The publicly traded firm did not disclose the name of its new investors. The firm said it sold appr... READ MORE...
posted on Thursday, February 2, 2012
Illumina Board Ponders Takeover Offer
San Diego-based life sciences tools developer Illumina said today that its board of directors will be reviewing the usnolicited offer by Roche to acquire the firm, for $44.50 per share in cash. Roche made the offer--which is worth $5.7 bill... READ MORE...
posted on Friday, January 27, 2012
Amgen to Acquire Micromet For $1.16B
Thousand Oaks-based Amgen announced today that it is acquiring Micromet, a biopharmaceuticals firm based in Germany and Rockville, Maryland, in a deal worth $1.16 billion. Amgen said it will pay $11 per share in cash for Micromet, which is ... READ MORE...
posted on Thursday, January 26, 2012
KFx Medical Gets Patent
Carlsbad-based KFx Medical said Tuesday that it has scored a U.S. Patent, covering its knotless double row rotator cuff repair technology, which is used in its line of implant products. U.S. Patent No. 8,100,942 was granted by the US Patent... READ MORE...
posted on Wednesday, January 25, 2012
Verdezyne Gains Patent
Carlsbad-based Verdezyne, the venture backed developer of biofuels technology, said today that it has been granted a United States Patent. The firm said the patent, No. 8,093,037, covers its engineered microorganisms used to enable yest to ... READ MORE...
posted on Tuesday, January 17, 2012
SkinMedica Buys Makeup Firm
Carlsbad-based SkinMedica, a venture backed cosmaceuticals firm developing skin care products, said Monday that it has acquired Colorescience, a makeup company developing science-based mineral makeups. Financial terms of the buy were not di... READ MORE...
posted on Monday, January 9, 2012
Uptake Medical Raises Series C
Tustin-based Uptake Medical, the developer of treatments for emphysema led by R. King Nelson, announced today that it has raised a Series C funding round. Size of the round was not announced. The round was led by Crescent Point Group (Singa... READ MORE...
posted on Monday, January 9, 2012
Yardi Buys Software Firm
Santa Barbara-based Yarsi, which develops software for property management, said Thursday afternoon that it has acquired ALMSA Corporation, a provider of software for the assisted living industry. Financial terms of the buy were not disclos... READ MORE...
posted on Thursday, January 5, 2012
Arrowhead Research Inks Deal With Alnylam
Pasadena-based Arrowhead Research and RNAi therapeutics firm Alnylam Pharmaceuticals announced this morning that the two are in a collaboration and licensing agreement. Financial details of the agreement were not announced. THe two said tha... READ MORE...
posted on Thursday, January 5, 2012
NeuroGenetic Pharmaceuticals Scores Investment
San Diego-based NeuroGentic Pharmaceuticals, a firm development treatments for Alzheimer's disease, said today that it has scored an investment round from Abbot Biotech Ventures. Size of the round was not announced. NeuroGenetic said the in... READ MORE...
posted on Wednesday, January 4, 2012
Marshall Edwards Raises $2M In Private Placement
San Diego-based Marshall Edwards, a publicly held firm focused on development of oncology drugs, said Thursday that it has raised $2M in a private placement. The funding came from its majority shareholder, Novogen Limited. Marshall Edwards ... READ MORE...
posted on Thursday, December 29, 2011
Meritage Pharma Gets $20M In Deal With ViroPharma
San Diego-based Metritage Pharma, which is developing drugs for treating chronic inflammatory diseases of the esophagus, is gaining up to $20M from ViroPharma, which is buying an exclusive option to acquire Meritage. ViroPharma said it paid... READ MORE...
posted on Friday, December 23, 2011
Aviir To Raise Up To $30M
Irvine-based Aviir, a venture-backed biotech firm targeting cardiac disease assessment, said late Monday that it has reached an agreement to raise up to $30M in a financing round. The firm said the round includes an initial $10M, plus up to... READ MORE...
posted on Monday, December 19, 2011
Amgen Inks $400M Deal With Generics Maker Watson Pharmaceuticls
Thousad Oaks-based Amgen said Monday that it has inked a $400M, co-development deal with Watson Pharmaceuticals, where they two will work together on oncology antibody biosimilar medicines. The two said that Amgen will assume primarily resp... READ MORE...
posted on Monday, December 19, 2011
Somaxon Cuts Staff, Looks for Buyer
San Diego-based Somaxon Pharmaceuticals, a developer of sleep medication, said today that it has cut 60 percent of its non-field based employees, and has hired a financial advisor to help sell the company. The firm said it has hired Stifel ... READ MORE...
posted on Monday, December 19, 2011
Independa Ties Sensors Into Health Monitoring Service
San Diego-based Independa, the venture backed provider of health monitoring systems for the elderly, announced this week that it has launched a new set of health, safety, and activity sensors which connect into its services. The company--wh... READ MORE...
posted on Thursday, December 8, 2011
Tribogenics Lands $2.5M For Portable X-ray Technology
Los Angeles-based Tribogenics, a startup working on technology to bring elements of Star Trek's "tricorder" to life, said this morning that it has raised $2.5M in a venture funding round. The firm, a spinoff of UCLA whose technology has bee... READ MORE...
posted on Tuesday, December 6, 2011
Qualcomm Launches Medical Devices Subsidiary, $100M Fund
San Diego-based Qualcomm announced this morning that it has created a new, wholly owned subsidiary called Qualcomm Life, which will focus on wireless solutions for the medical devices market. The new subsidiary will also backed by a new, ve... READ MORE...
posted on Monday, December 5, 2011
Harbor MedTech Raises $600K For Wound Healing Technology
Orange County-based Harbor MedTech, a developer of wound healing technology, has raised $600,000 in a funding round from private investors, the firm disclosed today, to help the firm grow and further develop its products. Harbor MedTech is ... READ MORE...
posted on Wednesday, November 30, 2011
eBioscience Acquired By Affymetrix
San Diego-based eBioscience, a developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, is being acquired by Affymetrix, Affymetrix said Wednesday. Affymetrix said it is paying $330M in cash... READ MORE...
posted on Wednesday, November 30, 2011
Verdezyne Opens Pilot Plant
Carlsbad-based Verdezyne, a developer of biotechnology used to produce renewable chemicals and fuels, announced today that it has opened its first pilot plant. The company said the plant will produce adipic acid, a key component of nylon. T... READ MORE...
posted on Wednesday, November 30, 2011
AcuFocus Sees $65M
Irvine-based AcuFocus, a maker of corneal inlays for treating presbyopia, announced this morning that it has raised $65M in a funding round. The ronud was led by Cowen Healthcare Royalty Partners, and also included SV Life Sciences, Versant... READ MORE...
posted on Tuesday, November 29, 2011
Puma Biotechnology Raises $60M
Los Angeles-based Puma Biotechnology, a developer of biopharmaceuticals aimed at treating cancer, said this morning that it has completed a second tranche of a $60M private financing. The company said that Leerink Swann LLC was the lead pla... READ MORE...
posted on Wednesday, November 23, 2011
Excaliard Pharmaceuticals Acquired By Pfizer
San Diego-based Excaliard Pharmaceuticals, a developer of biopharmaceuticals for treating skin scarring, has been acquired by Pfizer. Financial terms of the buy were not disclosed. Excaliard was venture backed by RiverVest, Alta Partners, P... READ MORE...
posted on Tuesday, November 22, 2011
Scripps Institute, IBM Look To PCs to Cure Malaria With Jeopardy Winnings
La Jolla-based biomedical research nonprofit Scripps Research Institute and IBM said this morning that they are looking for the public's help, in volunteering to donate their computer time to help a new effort to cure malaria, funded by IBM... READ MORE...
posted on Friday, November 18, 2011
Domain, Versant Score Exit At Clovis Oncology
Two, Southern California venture investors have scored an exit this morning with the IPO of Clovis Oncology. San Diego's Domain Associates and Newport Beach-based Versant Ventures are both significant investors in Clovis, which priced its I... READ MORE...
posted on Wednesday, November 16, 2011
Ambit Biosciences Names CEO
San Diego-based Ambit Biosciences said today that it has named Michael A. Martino as its new President and CEO. Ambit, which is developing small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicati... READ MORE...
posted on Wednesday, November 16, 2011
SoCal Investors Await Clovis Oncology IPO
Two Southern California venture firms are among the investors who are awaiting an expected IPO of Clovis Oncology, a developer of cancer drugs, this week. Clovis Oncology, based in Colorado, is expected to price its IPO this week, according... READ MORE...
posted on Tuesday, November 15, 2011
InTouch Health Names CFO
Santa Barbara-based InTouch Technologies, which develops telemedicine products, said this morning that it has named Stephen L. Wilson as Executive Vice President and Chief Financial Officer. Wilson was most recently Executive Vice President... READ MORE...
posted on Monday, November 14, 2011
Rempex Pharmaceuticals Snags $67.5M
San Diego-based Rempex Pharmaceuticals, a biopharmaceuticals firm addressing antibiotic resistance, announced this morning that it has raised $67.5M in an initial close of a Series B financing round. The round came from Frazier Healthcare V... READ MORE...
posted on Wednesday, November 9, 2011
Perminova Raises $7M For Surgical Software
La Jolla-based Perminova announced Tuesday that it has raised $7M in a funding round, which it will use to develop its web-based cardiovascular procedure software. Perminova's software provides scheduling, workflow, surgical data, and billi... READ MORE...
posted on Tuesday, November 8, 2011
ACADIA Pharmaceuticals Starts Phase I Studies
San Diego-based ACADIA Pharmaceuticals reported this morning that the U.S. Food and Drug Administration has completed its review of the firm's New Drug Application for AM-831, its small molecule for treatment of schizophrenia, and it is adv... READ MORE...
posted on Monday, November 7, 2011
Prolacta Lands Series D
Monrovia, California-based Prolatca Bioscience, which supplies human milk-based fortifiers for premature infants, said today that it has closed a Series D funding round. The round came from Health Evolution Partners. Size of the round was n... READ MORE...
posted on Thursday, November 3, 2011
ImaginAB Gets $2.3M
Los Angeles-based ImagineAb, a spinout of UCLA which is developing diagnostic imaging technology, reported Monday that it has been awarded $2.3M in funding, from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR... READ MORE...
posted on Tuesday, November 1, 2011
Arrowhead Research Names COO
Pasadena-based Arrowhead Research, which develops biotherapeutics and other technology, announced today that it has named Bruce Given, M.D., as its Chief Operating Officer. Given was previously CEO of Leonardo Biosystems, and also has been ... READ MORE...
posted on Thursday, October 27, 2011
Analytix On Demand Acquires Firm, Becomes CentraMed
Irvine-based Analytix On Demand, a developer of business intelligence software for the healthcare market, said Tuesday that it has acquired healthcare consulting and education firm Integrated Revenue Management, Inc.. Financial terms of the... READ MORE...
posted on Wednesday, October 26, 2011
Nantworks Buys Ziosoft
Los Angeles-based Nantworks, the business incubation and technology development firm headed by LA billionaire Patrick Soon-shiong, has acquired Ziosoft, a provider of medical imaging and visualization software. According to Ziosoft, which d... READ MORE...
posted on Wednesday, October 26, 2011
Patrick Soon-Shiong Aims At Pancreatic Cancer Treatments
The Chan Soon-Shiong Insitute for Advanced Health--one of the projects of that billionaire Patrick Soon-Shiong--said today, along with Soon-Shiong's incubator NantWorks, that Soon-Shiong has been working on a treatment for advanced metasta... READ MORE...
posted on Tuesday, October 25, 2011
Verenium Gets $16M in Credit Line
San Diego-based biotechnology firm Verenium announced this morning that it has scored credit lines totaling $16M, for the development of its enzyme development efforts. The firm said it has entered into an agreement with Comerica Bank and t... READ MORE...
posted on Thursday, October 20, 2011
Anadys Acquired By Roche
San Diego-based Anadys Pharmaceuticals, the developer of treatments for hepatitis C, said this morning that it has agreed to be acquired by Roche. The firm said it signed a definitive merger agreement where Roche will pay $3.70 per share fo... READ MORE...
posted on Monday, October 17, 2011
Amgen Expands Board
Thousand Oaks-based Amgen said Thursday evening that it has added Robert A. Bradway, the firm's current President and Chief Operating Officer, to the company's board. According to Amgen, the addition of Bradway brings its total board member... READ MORE...
posted on Friday, October 14, 2011
Caltech Engineers Use Legos, Google Smartphone For Smart Petri Dish
Researchers at the California Institute of Technology reported last week that they have created a "smart petri dish" which uses Google smart phones and Lego blocks, to automatically monitor cell growth in petri dishes. In a paper presented ... READ MORE...
posted on Tuesday, October 11, 2011
Inspiration Biopharmaceuticals Finds CEO
Laguna Niguel-based Inspiration Biopharmaceuticals, a developer of treatments for hemophilia, announced today that it has appointed John P. Butler as its new CEO. Butler replaces current CEO Michael Griffith, who becomes Chief Scientific Of... READ MORE...
posted on Tuesday, October 11, 2011
Medsphere Names Sales, Marketing VP
Carlsbad-based Medsphere Systems, which develops open source healthcare software, said today that it has named John Bright as Vice President of Sales and marketing. Bright joins the company from Henry Schein Medical Systems, and also has se... READ MORE...
posted on Tuesday, October 11, 2011
CoDa Therapeutics Lands $6M Credit Facility
San Diego-based CoDa Therapeutics, a developer of biopharmaceuticals for wound care, has scored $6M in a credit facility, according to the firm's lender. Square 1 Bank said that it has provided CoDa Therapeutics with a $6M term loan. Terms ... READ MORE...
posted on Thursday, October 6, 2011
ImThera Medical Snags $16M
San Diego-based ImThera Medical, a developer of medical devices to treat sleep apnea, has raised $16M in an initial funding round from publicly held Cyberonics, plus its other investors Cyberonics said Wednesday. ImThera is developing an im... READ MORE...
posted on Wednesday, October 5, 2011
JMI Equity Invests In Studer Group
San Diego-based private equity firm JMI Equity has invested in Studer Group, a provider of healthcare performance improvement services for hospitals and medical groups. Size of the investment was not disclosed. Financial details of the inve... READ MORE...
posted on Wednesday, October 5, 2011
ReShape Medical Names CEO
San Clemente-based ReShape Medical, a developer of a non-surgical weight loss device, said today that it has named Richard Thompson as the firm's president and CEO. Thompson was previously founder, president, and CEO of Luminous Medical, an... READ MORE...
posted on Tuesday, October 4, 2011
Prolacta Links With National Milk Bank
Monrovia-based Prolacta Bioscience, the venture-backed provider of human milk-based fortifiers for premature infants, said today that it has inked a deal with the National Milk Bank, where the firm will process all of the milk through the b... READ MORE...
posted on Friday, September 23, 2011
Ambrx In Deal With Bristol-Myers Squibb
La Jolla-based Ambrx, the biopharmaceuticals developer, and Bristol-Myers Squibb said today that the two are in a collaboration. According to the companies, Bristol-Myer Squibb will receive exclusive, worldwide rights to research, develop, ... READ MORE...
posted on Thursday, September 22, 2011
Two Biotech Labs Set Up Shop In San Diego
In a demonstration of the amount of activity in San Diego's biotech industry, two, separate companies announced new biotech laboratories opened up in San Diego Wednesday. Both Isis Pharmaceuticals and the J. Craig Venter Institute said they... READ MORE...
posted on Thursday, September 22, 2011
Independa Raises $1.6M
San Diego-based Independa, which operates a service to help family and professional caregivers monitor loved ones, has raised $1.6M in a seed funding round, the firm said today. The funding came from Miramar Venture Partners and CityHill Ve... READ MORE...
posted on Wednesday, September 21, 2011
KYTHERA Biopharmaceuticals Raises $37.4M
Los Angeles-based KYTHERA Biopharmaceuticals, a developer of aesthetic medicine products, said today that it has raised $37.4M in a series D funding round. The round included new investors Foley Ventures and Latham and Watkins, and also inc... READ MORE...
posted on Monday, September 19, 2011
Celerus Diagnostics Ups Series C To $10M
Carpinteria-based Celerus Diagnostics, a developer of pathology analysis equipment, has now raised $10M in a Series C funding, according to a regulatory filing from the firm Thursday. Details on the funding have not been released by the com... READ MORE...
posted on Thursday, September 15, 2011
RF Surgical Systems Gets $12M
RF Surgical Systems, a developer of systems used to keep track of surgical sponges during surgery procedures, announced Tuesday that it has raised $12M in funding. The firm--which has its R&D facilities in San Diego--said the round was led ... READ MORE...
posted on Tuesday, September 13, 2011
Zynx Health In Big Hiring Push
In good news for the LA jobs market, another Los Angeles company is reporting big hiring plans. Los Angeles-based Zynx Health, a developer of clincial decision support software for the healthcare market, said today that it has opened up ove... READ MORE...
posted on Monday, September 12, 2011
Amgen Backs Therapeutic Antibody Firm
Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences, Amgen Ventures was one of the investors in a $10.6M, Seri... READ MORE...
posted on Thursday, September 8, 2011
Uptake Medical Hires European GM
Tustin-based Uptake Medical, the developer of a minimally invasive treatment for severe emphysema, announced today that it has named Lloyd Mencinger as its European General Manager. Mencinger most recently served at Tenent Healthcare, and a... READ MORE...
posted on Tuesday, September 6, 2011
Amgen Backs Small Molecule Drug Firm
Amgen Ventures, the venture capital arm of Thousand Oaks-based Amgen, has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes. According to Fremont, California-based Ardelyx, ... READ MORE...
posted on Wednesday, August 31, 2011
ConjuChem, Led By Dr. Patrick Soon-Shiong, Relaunches In LA
ConjuChem, a biotechnology firm focused on developing medicines based on therapeutics peptides, said today that it has relaunched the company, and is now based in Los Angeles under the management of Patrick Soon-Shiong, M.D. The firm, which... READ MORE...
posted on Tuesday, August 30, 2011
Inogen Gets Debt Financing
Santa Barbara-based Inogen, a manufacturer of oxygen therapy products for the home healthcare industry, has scored a $6M credit facility, according to Square 1 Bank. Terms of the credit facility were not announced. Inogen develops home oxyg... READ MORE...
posted on Wednesday, August 24, 2011
Awarepoint Pulls In $27M More
San Diego-based Awarepoint, the developer of real-time, location systems for the healthcare market, announced this morning that it has raised $27M in new financing, as part of a Series F round. The round was led by new investor Kleiner Perk... READ MORE...
posted on Wednesday, August 24, 2011
Zogenix Plans Follow-On Offering
San Diego-based Zogenix, the developer of delivery systems for administering pain medication, is planning a follow on offering of its stock. According to an S-1 filed by the firm today, it is selling 12M shares of its common stock, and is l... READ MORE...
posted on Wednesday, August 24, 2011
PBS Biotech Acquires Integrity CMI
Camarillo-based PBS Biotech, a developer of bioreactors for the biotech market, said Tuesday that it has acquired Camarillo-based Integrity CMI, a medical device design and manufacturing companies. Financial terms of the deal were not discl... READ MORE...
posted on Tuesday, August 23, 2011
Masimo Sued Over Patent
Irvine-based Masimo, the maker of pulse oximetry and other medical monitoring devices, has been sued for patent infringement by competitor Essential Medical Devices, Inc.. According to a filing in the Delaware District Court Friday, Essenti... READ MORE...
posted on Monday, August 22, 2011
Sonendo Raises $5.9M
Laguna Hills-based Sonendo, a developer of dental surgery equipment, has raised $5.9M in a funding round, according to a regulatory filing by the firm this week. According to the filing, the $5.9M is part of an ongoing $6.4M equity round. N... READ MORE...
posted on Thursday, August 18, 2011
TCA Funds PharmaSecure
The Tech Coast Angels, Southern California's biggest and most active angel investing group, appears to be backing a developer of prescription drug validation systems, based in Lebanon, N.H. According to a regulatory filing from PharmaSecure... READ MORE...
posted on Wednesday, August 17, 2011
Quality Systems Buys CQI Solutions
Irvine-based Quality Systems, a developer of electronic health records and other health-related IT products, said Wednesday that it has agreed to acquire CQI Solutions, a provider of surgery information systems. Financial terms of the acqui... READ MORE...
posted on Wednesday, August 17, 2011
Acutus Medical Raises $1M
San Diego-based Acutus Medical, a developer of medical devices for treating cardiac arrhythmia, said today that it has received $1M in a funding round. The round came form Index Ventures and un-named private investors. Acutus Medical said i... READ MORE...
posted on Monday, August 8, 2011
Avanir Pharmaceuticals Names Research VP
Aliso Viejo-based Avanir Pharmaceuticals said today that it has named Dr. Joao Siffert as its Senior Vice President Research and Development. Siffert was previously VP and Chief Medical Officer at Ceregene, and has also served at Avera Phar... READ MORE...
posted on Monday, August 8, 2011
Vessix Vascular Takes $23M
Laguna Hills-based Vessix Vascular, a developer of catheter technology, said this week that it has raised $23M in a Series B financing round. The round was led by Edmond de Rothschild Investment Partners (EdRIP), and also included Orbimed A... READ MORE...
posted on Thursday, August 4, 2011
KFx Medical Files Patent Suit Against Competitor
San Diego-based KFx Medical, the venture-backed developer of medical devices used for orthopedic surgery, said this week that it has launched a patent infringement suit against a competitor, Arthrex. KFx medical alleges that Arthrex is infr... READ MORE...
posted on Thursday, August 4, 2011
Cynvenio Biosystems Bolsters Board
Westlake Village-based Cynvenio Biosystems, a developer of medical diagnostics technology, said Wednesday that it has bolstered its board of directors with two appointments. According to Cynvenio, Amit Munshi and Simon Raab have joined the ... READ MORE...
posted on Wednesday, August 3, 2011
Ellipse Technologies Gains $17.6M
Irvine-based Ellipse Technologies, a developer of minimally invasive treatments for spinal deformities, said Tuesday that it has raised $17.6M in a Series C financing round. The round came form HBM BioVentures and BioStar Ventures, along wi... READ MORE...
posted on Tuesday, August 2, 2011
CareFusion Completes Acquisition of Rowa
San Diego-based CareFusion, the developer of medical devices, said today that it has completed its acquisition of German firm Rowa, a firm which develops robotics medical storage and retrieval systems for pharmacies. The deal was worth $150... READ MORE...
posted on Monday, August 1, 2011
Nexus Biosystems Acquired For $79M
Poway-based Nexus Biosystems, a developer of automated compound and sample management equipment for the life sciences industry, has been acquired by Brooks Automation in a deal worth $79M, the firms said earlier this week. According to Broo... READ MORE...
posted on Thursday, July 28, 2011
Amira Pharmaceuticals Acquired By Bristol-Myers Squibb
San Diego-based Amira Pharmaceuticals, a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb, the firms said late Thursday. Bristol-Myers Squibb said... READ MORE...
posted on Thursday, July 21, 2011
Awarepoint Claims Record Quarter
San Diego-based Awarepoint Corporation, the developer of real-time location systems for the hospital market, claimed today that it had a record quarter, booking over forty-six hospitals and health systems. The firm said the number of bookin... READ MORE...
posted on Wednesday, July 20, 2011
Allergan Buys Vicept Therapeutics
Irvine-based Allergan said this morning that it has acquired Vicept Therapeutics, a developer of a compound for treating the erythema of rosacea. According to Allergan, it will pay $75M in cash up front, plus up to $200M in earnout dependen... READ MORE...
posted on Tuesday, July 19, 2011
Amgen Resolves Patent Suit With Teva
Thousand Oaks-based Amgen said Friday afternoon that it has resolved a patent litigation suite with Teva. The firm said that the United States District Court in Pennsylvania has issued a final judgement and permanent injunction against Teva... READ MORE...
posted on Monday, July 18, 2011
Naviscan Bolsters Board
San Diego-based Naviscan, the developer of 3D medical imaging technology, said today that it has added Andre Cheng, M.D., Ph.D., to its board of directors. Cheng has previously served as VP of Medical Affairs and Reimbursement at Acclarent,... READ MORE...
posted on Thursday, July 14, 2011
Kite Pharma Names Scientific Officer
Los Angeles-based Kite Pharma, a biopharmaceuticals firm focused on cancer treatments, announced this morning that it has appointed Adrian Bot, M.D., Ph.D., as its Chief Scientific Officer. Dr. Bot joins the company from MannKind Corp., whe... READ MORE...
posted on Monday, July 11, 2011
Amgen On Final Space Shuttle Mission
Thousand oaks-based biotech giant Amgen said Tuesday that the firm is taking part in a preclinical test on the final, NASA Space Shuttle mission scheduled to launch Friday. According to Amgen, it is in a collaboration with UCB and NASA Ames... READ MORE...
posted on Wednesday, July 6, 2011
ResMed Buys Irish Firm
San Diego-based ResMed, a developer of medical equipment for treating sleep disorders, said today that it has acquired Irish medical technology firm BiancaMed Ltd.. Financial terms of the buy were not disclosed. BiancaMed is a developer of ... READ MORE...
posted on Wednesday, July 6, 2011
CareFusion Buys German Firm
San Diego-based CareFusion, the developer of infusion pumps and other medical products, reported today that it is acquiring Rowa, a German firm focused on robotic medical storage and retrieval systems. The deal was worth approximately $150M... READ MORE...
posted on Tuesday, July 5, 2011
Tenex Health Raises $5M
Lake Forest-based Tenex Health, a developer of minimally invasive for treating tendon injuries, said today that it has raised $5M in a series A financing round. The funding was led by VCI Partners. Tenex said the new funding comes on top of... READ MORE...
posted on Thursday, June 30, 2011
Experian Buys Medical Present Value
Costa Mesa-based Experian, the provider of credit information and related services, said today that it has acquired venture-backed Medical Present Value, a provider of revenue cycle management software to physicians. Experian said it would ... READ MORE...
posted on Tuesday, June 28, 2011
Ivantis Scores $17M For Glaucoma Treatments
Irvine-based Ivantis, a developer of medical devices for the treatment of glaucoma, announced today that it has raised $17M in a new, second round of funding. The round came from New Enterprise Associates and Delphi Ventures. Ivantis said i... READ MORE...
posted on Monday, June 27, 2011
OSI Systems Gets $3M Contract
Hawthorne-based OSI Systems, the developer of specialized electronics products for the security and healthcare industry, reported today that it has won a $3M contract from a New Jersey health system customer. The award went to its healthcar... READ MORE...
posted on Monday, June 27, 2011
Clovis Oncology, With SoCal Backers, Files For IPO
In another, Southern California linked IPO, a Colorado anti-cancer firm. Clovis Oncology, has filed for a debut on the NASDAQ Global Market. Clovis Oncology is backed by Southern California investors Domain Associates and Versant Ventures, ... READ MORE...
posted on Thursday, June 23, 2011
Amgen Gives Teachers $10,000 For Teaching Excellence
Thousand Oaks-based Amgen said today that it has awarded 34 science teachers with $10,000 each, in its 19th annual Amgen Award for Science Teaching Excellence. The firm awards the grants each year for "extraordinary" science teachers throug... READ MORE...
posted on Wednesday, June 22, 2011
Somaxon Gets $5M In PIPE
San Diego-based Somaxon Pharmaceuticals, a specialty pharmaceuticals firm working on insomnia on other drugs, said today that it has raised $5M in a private placement. The firm said it raised the $5M from Paladin Labs, Inc., and comes in co... READ MORE...
posted on Monday, June 13, 2011
Ambit Biosciences Raises $30M
San Diego-based Ambit Biosciences, which is developing cancer treatments, announced this morning that it has raised $30M in Series D-2 round of funding. The funding was led by Apposite Capital LLP, and also included prior investors Perseus-... READ MORE...
posted on Friday, June 10, 2011
Epiomed Therapeutics Gets Series A
Irvine-based Epiomed Therapeutics, a developer of small-molecule, anti-emetic and anti-motion sickness compounds, said this week that it raised a Series A funding round. The firm said the round came from NDI Capital. Financial details of th... READ MORE...
posted on Thursday, June 9, 2011
Access Scientific Raises $10M
San Diego-based Access Scientific, a developer of vascular access technology, said today that it has completed a $10M, financing round. The round was led by CAC, and also included the firm's prior investors. The firm said the funding will ... READ MORE...
posted on Thursday, June 9, 2011
Ambit Drops IPO Ambitions
San Diego-based Ambit Biosciences has dropped its IPO plans, according to the firm in a filing with the Securities and Exchange Commission Tuesday afternoon. According to the withdrawal request from Ambit, the firm decided that "terms curre... READ MORE...
posted on Tuesday, June 7, 2011
Billionaire Soon Shiong Funds Healthcare Systems Developer
Los Angeles billionaire entrepreneur Patrick Soon Shiong has made an investment in a healthcare technology firm Net.Orange, Net.Orange said today. The Texas firm provides a suite of web-based applications for the healthcare industry. Financ... READ MORE...
posted on Tuesday, June 7, 2011
Otonomy Ups Funding By $14.2M
San Diego-based Otonomy, a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M more in a tranched financing which was originally announced last August, according to a regulatory filing by ... READ MORE...
posted on Friday, June 3, 2011
Interview with Jake Winebaum, Brighter
Jake Winebaum is a veteran of the Southern California technology industry, having run and sold a number of successful, Southern California startups. His last success was Business.com, which he sold to R.R. Donnelly, and he also was behind e... READ MORE...
posted on Thursday, May 26, 2011
Prometheus Laboratories Acquired by Nestle
San Diego-based Prometheus Laboratories, a specialty pharmaceuticals and diagnostics firm, has been acquired by Nestle Health Sciences S.A., a subsidiary of Nestle S.A. Financial terms of the deal were not disclosed. The firms said that the... READ MORE...
posted on Tuesday, May 24, 2011
OSI Systems Gets $1.6M Contract
Hawthorne-based OSI Systems, a manufacturer of specialized electronic systems, reported today that it has scored a $1.6M contract. The firm said its Spacelabs Healthcare unit received the order from a South Carolina hospital, for a line of ... READ MORE...
posted on Monday, May 23, 2011
Aperio Adds To Board
Vista-based Aperio, which develops digital pathology equipment, said Thursday that it has named Thomas Bologna to its board of directors. Bologna is President and CEO of Orchid Cellmark, a provider of DNA identity testing services. Bologna ... READ MORE...
posted on Friday, May 20, 2011
AutoGenomics Pulls IPO
Vista-based AutoGenomics, a developer of molecular diagnostics hardware, has pulled its IPO, the firm said in a filing Wednesday evening. The firm said it has "elected not to pursue the sale of securities" but did not give a reason for the ... READ MORE...
posted on Thursday, May 19, 2011
Cameron Health Raises $107M
San Clemente-based Cameron Health, which is developing subcutaneous implantable defibrillators, said today that it has raised $107M in an equity financing round. The round was led by Alloy Ventures and Delphi Ventures. the firm said the fun... READ MORE...
posted on Wednesday, May 18, 2011
CytRx Sells Assets To Orphazyme
Los Angeles-based biopharmaceuticals firm CytRx said late last night that it has sold off the firm's molecular chaperone assets, to Denmark-based Orphazyme ApS. The deal is worth as much as $120M, if all development and commercialization mi... READ MORE...
posted on Tuesday, May 17, 2011
mobileStorm Turns Eyes Towards Healthcare
Los Angeles-based mobileStorm, the mobile and email messaging and marketing firm headed by Jared Reitzin, said Wednesday that it has launched a new, healthcare focused offering, and signed Humana as a beta client. The firm said its new "mob... READ MORE...
posted on Wednesday, May 11, 2011
Halozyme Therapeutics In $83M Licensing Deal
San Diego-based Halozyme Therapeutics, a developer of products for the insulin, cancer, dermatology and drug delivery markets, said today along with ViroPharma Incorporate that it is in a $83M licensing deal. The two said that Halozyme has ... READ MORE...
posted on Wednesday, May 11, 2011
Anti-AgingGames.com Launches Brain Fitness Site
Los Angeles-based Anti-AgingGames.com, a new startup offering up brain fitness games, has launched today, aiming at healthy people looking to help their memory, concentration, and focus. The site--whose games were designed by Atari founder ... READ MORE...
posted on Tuesday, May 10, 2011
NeuroVigil Gets Funding
La Jolla-based NeuroVigil, a firm developing non-invasive wireless brain recording technology and advanced computational analysis techniques, has raised a first round of funding, the firm said this week. Amount of the funding, and source, w... READ MORE...
posted on Wednesday, May 4, 2011
TCA Backs Cancer Testing Firm
The Tech Coast Angels, the largest and most active angel investment group in Southern California, is backing a firm developing testing for cervical cancer. According to fellow investor the Sand Hill Angels, OncoHealth Corporation has raised... READ MORE...
posted on Tuesday, May 3, 2011
Life Technologies Adds Board Member
Carlsbad-based Life Technologies, the developer of life sciences analysis equipment, said last week that it has named Dr. Ora Hirsch Pescovitz to its board of directors. Pescovitz is Executive Vice President for Medical Affairs and Health S... READ MORE...
posted on Monday, May 2, 2011
TRACON Pharmaceuticals Raises $14M
San Diego-based TRACON Pharmaceuticals, a firm developing cancer therapeutics, said this morning that it has raised $14M in a first tranche closing of a venture round. The round was led by JAFCO and Nextech Invest, and also included Arcus V... READ MORE...
posted on Wednesday, April 20, 2011
Sangart Raises $50M
San Diego-based Sangart, a firm developing products to prevent and treat ischemia and to stabilize the hemoglobin of sickle cell disease patients, said Tuesday that it has raised $50M in a Series G equity financing round. The round was led ... READ MORE...
posted on Tuesday, April 19, 2011
Awarepoint Acquires Competitor
San Diego-based Awarepoint, the developer of real time location systems for hospitals, said this morning that it has acquired Patient Care Technology Systems (PCTS). Financial terms of the acquisition were not disclosed. PCTS, based in Char... READ MORE...
posted on Tuesday, April 19, 2011
CoDa Therapeutics Adds $19M
San Diego-based CoDA Therapeutics, a developer of chronic wound healing biopharmaceuticals, announced this morning that it has raised $19.2M in a series B financing round. The round came from Domain Associates, GBS Venture Partners and BioP... READ MORE...
posted on Monday, April 18, 2011
Regulus Therapeutics Names Chief Scientific Officer
La Jolla-based Regulus Therapeutics, a biopharmaceuticals firm developing microRNA-based medicines, said this morning that it has named Neil W. Gibson as its Chief Scientific Officer. Gibson joins the firm from PFizer, and previously has se... READ MORE...
posted on Monday, April 18, 2011
Conatus Pharmaceuticals Adds $7.5M
San Diego-based Conatus Pharmaceuticals, a biopharmaceuticals firm working on treatments for hepatitis C, said this week that it has closed on an additional $7.5M in its Series B funding round. The round came from MPM Capital. The new fundi... READ MORE...
posted on Thursday, April 14, 2011
MabVax Therapeutics Gets SBIR Grant
San Diego-based MabVax Therapeutics, a biotechnology firm developing cancer treatments based on vaccine and antibody based therapies, said this morning that it has received $1.8M in a Phase 2, Small Business Innovation Research award. The a... READ MORE...
posted on Monday, April 11, 2011
Arrowhead Research Boosts Investment In Ablaris
Pasadena-based Arrowhead Research said Wednesday that it has boosted its stake in Ablaris Therapeutics, a firm developing treatments for obesity. According to Arrowhead Research, it invested $1.3M in a second close of a Series A financing r... READ MORE...
posted on Wednesday, April 6, 2011
Magnetecs Names CFO
Inglewood-based Magnetecs, a designer of robotic catherization control systems for minimally invasive surgery, announced today that it has named Clive Zickel as the firm's new Chief Financial Officer. Zickel has previously served at JPMorga... READ MORE...
posted on Thursday, March 31, 2011
Inspiration Biopharmaceuticals Raises Funding To $247M
Laguna Nigel-based Inspiration Biopharmaceuticals, a developer of treatments for hemophilia, has raised its latest funding to $247.6M, according to a regulatory filing by the firm today. Details on the funding have not been announced by the... READ MORE...
posted on Wednesday, March 30, 2011
Arena Pharmaceuticals Raises $35.5M in PIPE
San Diego-based Arena Pharmaceuticals, a publicly held developer of pharmaceuticals based on G protein-coupled receptors (GPCRs), announced this morning that it has raised $35.5M in a Series C convertible preferred stock financing. The fund... READ MORE...
posted on Tuesday, March 29, 2011
GenMark Diagnostics Appoints CFO
Carlsbad-based GenMark Diagnostics, a developer of molecular diagnostic systems, said Thursday that Paul Ross has been appointed as its Chief Financial Officer. Ross joins from Teledata Technology Solutions, and also has been at Meade Instr... READ MORE...
posted on Friday, March 18, 2011
Amylin Suspends Clinical Trial
San Diego-based Amylin Pharmaceuticals and partner Takeda Pharmaceutical Company reported this morning that they have suspended clinical activities on a Phase 2 study involving its obesity treatment. The firm said the study was voluntarily ... READ MORE...
posted on Wednesday, March 16, 2011
TriLink Gets SBIR
San Diego-based TriLink BioTechnologies, a biotech startup working on technology for improving PCR processes, said this morning that it has received a $100,000 Phase I, SBIR Grant from the National Institutes of Health. The firm said the fu... READ MORE...
posted on Tuesday, March 15, 2011
Astute Medical Raises $13M
San Diego-based Astute Medical, a firm working on developing diagnostic test using protein biomarkers, said this week that it has raised $13M in a financing round. The round was a Series B extension. The funding came from Domain Associates,... READ MORE...
posted on Thursday, March 10, 2011
Kite Pharma Raises $15M
Los Angeles-based Kite Pharma, a biopharmaceuticals firm developing treatments for cancer, said this morning that it has raised $15M in an initial round of funding. The funding was led by TPG Capital. As part of the funding, David Bonderman... READ MORE...
posted on Wednesday, March 9, 2011
Anabios Gets Angel Backing
Bonita, California-based Anabios, a stealth mode firm working on drug testing services for pain drugs, has scored an angel investment round from the Tech Coast Angels. The funding came from the TCA's new ACE Fund, the angel group's more for... READ MORE...
posted on Tuesday, March 8, 2011
Pharmaron Finds $40M
Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. The fi... READ MORE...
posted on Thursday, March 3, 2011
Uptake Medical Bolsters Board
Irvine-based Uptake Medical, a developer of non-surgical treatments for lung disease, said today that it has named Scott Huennekens to its board. Huennekens is President and CEO of Volcano Corporation, and also has served at Digirad Corpora... READ MORE...
posted on Tuesday, March 1, 2011
JMI Equity Invests In PointClickCare
San Diego- and Baltimore-based private equity firm JMI Equity has invested in PointClickCare, a developer of electronic health records software for the long-term care industry. Financial terms of the deal were not disclosed. PointClickCare ... READ MORE...
posted on Monday, February 28, 2011
Biomatrica Gets Investment From In-Q-Tel
San Diego-based Biomatrica, a developer of technology for storing biological samples at room temperature, announced this morning that it has scored an investment from In-Q-Tel, the investment arm of the U.S. intelligence community. Size of ... READ MORE...
posted on Wednesday, February 23, 2011
Calcimedia Gets $6M
La Jolla-based CalciMedica, a developer of small molecule drugs for the treatment of inflammatory and autoimmune diseases, said Thursday that it has raised $6M in a tranche of financing, after initiating a Phase I clinical trial of a treatm... READ MORE...
posted on Friday, February 18, 2011
Orexigen Therapeutics Loses CFO
San Diego-based Orexigen Therapeutics announced this morning that its CFO, Graham Cooper, is resigning from the firm. The company said that Cooper is resigning for personal reasons, and partially because he has been commuting from the San F... READ MORE...
posted on Thursday, February 17, 2011
Conatus Pharmaceuticals Raises $20M
San Diego-based Conatus Pharmaceuticals said Friday afternoon that it has closed a $20M, Series B funding round. The firm, which is developing treatments for Hepatitis C, said the funding was led by AgeChem Venture Fund, and also included A... READ MORE...
posted on Monday, February 14, 2011
Orexigen Therapeutics Cuts 40 Percent
San Diego-based Orexigen Therapeutics, which is developing biopharmaceuticals focused on treating obesity, said Wednesday afternoon that it is cutting 40 percent of its staff, or 23 employees. According to Orexigen, the move comes as a resu... READ MORE...
posted on Wednesday, February 9, 2011
Somaxon Pharmaceuticals Gets Line of Credit, Expands Sales Force
San Diego-based Somaxon Pharmaceuticals said this morning tha tit has scored a $15M, revolving line of credit from Comerica Bank, and also engaged a contract sales force firm. Somaxon said it has tied with Publicis Touchpoint Solutions to r... READ MORE...
posted on Tuesday, February 8, 2011
Beckman Coulter Acquired By Danaher For $6.8 Billion
Orange County-based Beckman Coulter, a maker of biomedical testing equipment, said today that it is in a merger agreement with Danaher, where Danaher will buy the firm for $6.8 billion. The deal is worth $83.50 per share in cash, which the ... READ MORE...
posted on Monday, February 7, 2011
ReVision Optics Names CEO
Lake Forest-based ReVision Optics, which is developing an implantable microlens for treating vision problems, said today that it has named John t. Kilcoyne as its CEO and President. Kilcoyne was most recently Chairman and CEO of Micrus Endo... READ MORE...
posted on Monday, February 7, 2011
Glaukos Raises $29.5M
Laguna Hills-based Glaukos, which is developing a medical device for the treatment of glaucoma, has raised $29.5M in a Series E round, the firm confirmed Thursday. According to Richard Harrison, the firm's CFO, the funding was led by Merite... READ MORE...
posted on Thursday, February 3, 2011
CareFusion Sells Distribution Business For $130M
San Diego-based CareFusion, which develops medical products such as pumps, ventilators, patient identification systems, and more, said this morning that it is selling its CareFusion International Surgical Products (ISP) business to Medline,... READ MORE...
posted on Thursday, February 3, 2011
Somaxon Pharmaceuticals Names VP
San Diego-based Somaxon Pharmaceuticals announced today that it has appointed Robert Cutler as Vice President Business Development. Cutler was most recently at Biogen Idec, having served as Senior Director Business Development, as well as A... READ MORE...
posted on Thursday, February 3, 2011
Patrick Soon-Shiong Buys Vitality Corp.
Patrick Soon-Shiong, the Los Angeles area biotech billionaire, has acquired Vitality Corp., a Cambridge, Massachusetts maker of "smart pills." Financial terms of the acquisition were not disclosed. According to Vitality, the acquisition wil... READ MORE...
posted on Wednesday, February 2, 2011
VertiFlex Raises $14M For Spinal Implants
San Clemente-based VertiFlex, a developer of medical devices for the treatment of spine disorders, said this afternoon that it has raised $14M in a equity placement. The funding came from Aberdare Ventures, Alta Partners, New Enterprise Ass... READ MORE...
posted on Tuesday, February 1, 2011
BAROnova Gets $5.2M
Goleta-based BAROnova, a developer of medical devices to treat obesity, has raised another $5.2M in funding, according to numbers released earlier this month in the PricewaterhouseCoopers/NVCA MoneyTree report. The funding has not yet been ... READ MORE...
posted on Monday, January 31, 2011
Ligand Buys CyDex Pharmaceuticals
San Diego-based Ligand Pharmaceuticals said Wednesday afternoon that it has acquired CyDex Pharmaceuticals, a Kansas-based drug reformulation firm. Ligand said it will pay $31.2M in upfront cash, $4.3M at the one year anniversary of closing... READ MORE...
posted on Wednesday, January 26, 2011
Amgen Acquires Firm For $1 Billion
Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex, a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. Amgen said it will pay up to $1 billion for the company,... READ MORE...
posted on Monday, January 24, 2011
Genoptix Acquired By Novartis For $470M
San Diego-based Genoptix, a publicly held provider of laboratory services to the hematology and oncology market, said this morning that it is in a definitive merger agreement to be acquired by Novartis. According to Genoptix, the deal is wo... READ MORE...
posted on Monday, January 24, 2011
TCA Funds Cognition Therapeutics
The Tech Coast Angels, the largest angel investment group in Southern California, is part of a syndicate funding Pittsburgh-based Cognition Therapeutics, a drug discovery firm focused on Alzheimer's. According to Cognition, it raised $2.5M ... READ MORE...
posted on Thursday, January 20, 2011
Amgen Sells Fremont Facility
Thousand Oaks-based Amgen said Tuesday afternoon along with Boehringer Ingelheim, that the firm has agreed to sell rights in and substantially all of the assets of its Fremont, Calfiornia development and manufacturing facility. According to... READ MORE...
posted on Wednesday, January 19, 2011
Illumina Expands in Latin America
San Diego-based Illumina, which manufactures genetic sequencing tools for the life sciences industry, said late Tuesday that it has opened up a new office in Sao Paolo, Brazil, to focus on business across Latin America. Illumina said the of... READ MORE...
posted on Wednesday, January 19, 2011
ADVENTRX Pharmaceuticals Raises $22.5M, Plans Acquisition
San Diego-based ADVENTRX Pharmaceuticals said this morning that it has raised $22.5M in funding, via a registered direct offering to RA Capital Management and other investors. According to the publicly traded firm, the new funding will go t... READ MORE...
posted on Friday, January 7, 2011
Amgen, Xencor In Development Deal
Thousand Oaks-based Amgen, and Monrovia-based Xencor said Thursday that the two firms are in a co-development dual around a new novel antibody for treating autoimmune diseases. According to the two, Amgen has gained an option to an exclusiv... READ MORE...
posted on Thursday, January 6, 2011
Qualcomm Gets Design Win In Blood Glucose Meter
San Diego-based Qualcomm said today that the firm's wireless machine-to-machine modules have been designed into a blood glucose meter product from Telcare Incorporated. According to Qualcomm its Internet of Everything Module (IEM) has been ... READ MORE...
posted on Tuesday, January 4, 2011
Aperio Names CFO
Vista-based Aperio, a provider of digital pathology products, said this week that it has named Patrick Yount as its Chief Financial Officer. Yount joins the firm from Univita Health, and has served at Axia Health Management, Biosensors Inte... READ MORE...
posted on Thursday, December 23, 2010
OSI Systems Gets $3M Order
Hawthorne-based OSI Systems, a developer and manufacturer of specialized electronic systems, said today that it has received a $3M order from a Washington state hospital. The firm said its Spacelabs Healthcare division received the $3M orde... READ MORE...
posted on Tuesday, December 21, 2010
Capricor Gets $2M
Los Angels-based Capricor, a firm developing stem cell technology to regenerate damaged heart tissue, announced Friday that it has raised $2M in a funding round. The round came from Broadview Ventures and individual investors. According to ... READ MORE...
posted on Monday, December 20, 2010
Optimer Pharmaceuticals Names VP
San Diego-based Optimer Pharmaceuticals said today that it has named Gregory Papaz as its Senior Vice President of Commercial Operations. Papaz was most recently at Genentech, and als ohas worked at Roche Pharma, Sanofi-Aventis, and Marion ... READ MORE...
posted on Monday, December 20, 2010
Amgen Gives $1.8M To Teach For America
Thousand Oaks-based Amgen, via its nonprofit foundation, the Amgen Foundation, said Friday that it is giving $1.8M to the Teach For America effort. According to the two, the funding will go towards increasing the number of math and science ... READ MORE...
posted on Friday, December 17, 2010
Specialists On Call Finds $11.73M
Westlake Village-based Specialists On Call, a firm developing a service to provide physician specialists to urban, suburban, and other hospitals via videoconferencing, has raised around $11.73M in a series of fundings, according to regulato... READ MORE...
posted on Thursday, December 16, 2010
Gen-Probe Buys GTI Diagnostics
San Diego-based Gen-Probe has acquired GTI Diagnostics, a specialty diagnostics firm focused on the transplantation, blood bank and specialty coagulation markets, the firm said Wednesday. The deal was worth $53M in cash. GTI was owned by pr... READ MORE...
posted on Thursday, December 16, 2010
Endologix Completes Nellix Buy
Irvine-based Endologix said today that it has completed its acquisition of Nellix, a developer of a medical device for the treatment of Abdominal Aortic Anerysms (AAAs). The acquisition had been originally announced in october. Endologix wi... READ MORE...
posted on Tuesday, December 14, 2010
SPK Capital Funds Pharmacy Services Firm
Los Angeles-based SPK Capital, an investment firm, has funded San Francisco-based Pipeline Healthcare, Pipeline said last week. Pipeline said SPK Capital led a $2.5M, Series A funding round for the firm. Pipeline Healthcare is a provider of... READ MORE...
posted on Monday, December 13, 2010
Prometheus Laboratories, UCLA In Research Deal
San Diego-based Prometheus Laboratories, a developer of specialty pharmaceuticals, and the Regents of the University of California, Los Angeles campus, said Thursday night that they are in a exclusive research agreement. The two said that U... READ MORE...
posted on Friday, December 10, 2010
Sofie Biosciences Gets $2M
Culver City-based Sofie Biosciences, a firm developing agents and devices for molecular imaging, said today that it has raised $2M in funding. The round came from Cycad Group and other investors. Sofie Biosciences technology is being applie... READ MORE...
posted on Wednesday, December 8, 2010
BioIQ Simplifies Wellness Service
Santa Barbara-based BioIQ, the diagnostic testing and screening service provider headed by Justin Bellante, said Tuesday that it has simplified access to personal health records on the site. The firm--which offers up home test kits and scre... READ MORE...
posted on Tuesday, December 7, 2010
Awarepoint Raises $9M
San Diego-based Awarepoint, a developer of enterprise, real-time location systems for the hospital market, has raised $9M in a financing round, the firm has announced. According to Awarepoint, the funding came from Cardinal Partners, Jafco ... READ MORE...
posted on Monday, December 6, 2010
Prolacta Bioscience Renews With Breast Milk Group
Monrovia-based Prolacta Bioscience, the venture backed firm which is extracting nutritional fortification from human breast milk, used to help premature and other ill infants, said Wednesday that it has renewed an agreement with the Interna... READ MORE...
posted on Wednesday, December 1, 2010
Awarepoint Names CEO
San Diego-based Awarepoint, a developer of real-time, asset and patient tracking products for hospitals, said today that it has named Jay Deady as the company's new President and CEO. Deady was most recently EVP of Client Solutions for Ecli... READ MORE...
posted on Wednesday, December 1, 2010
Histogen Raises $10M
San Diego-based Histogen, a developer of regenerative medicine products, announced today that it has raised $10M in a Series A financing round. The financing came from private investors, including Secure Medical, Leonard Lavin, Lordship Ven... READ MORE...
posted on Tuesday, November 30, 2010
Total Immersion Applies Technology To Surgery
Los Angeles-based Total Immersion, the developer of augmented reality software tools, reports today that it has added Los Angeles-based Vantage Surgical Systems as a partner. According to Total Immersion, Vantage is looking to use its augme... READ MORE...
posted on Tuesday, November 30, 2010
Awarepoint Raises $3.2M
San Diego-based Awarepoint, a developer of real time, location monitoring systems for hospitals, has raised another $3.2M in capital, according to a recent regulatory filing by the firm. The filing indicates current investors Venrock, JAFCO... READ MORE...
posted on Monday, November 29, 2010
Amgen Gets FDA Approval On Bone Drug
Thousand Oaks-based Amgen said Thursday that it has received U.S. Food and Drug Admnistration (FDA) approval on its denosumab treatment for reducing fractures and other bone problems in cancer patients. The new drug will be sold under the n... READ MORE...
posted on Friday, November 19, 2010
BeneChill Finds $600K
San Diego-based BeneChill, a firm developing medical devices for treatment of cerebral ischemia, has raised $600,000 as part of $1.2M in debt funding, according to a regulatory filing by the firm this week. Source of the new funding was not... READ MORE...
posted on Tuesday, November 16, 2010
Aires Pharmaceuticals Raises $20M, Inks Exclusive With Novartis
San Diego-based Aires Pharmaceuticals, a developer of treatments for pulmonary arterial hypertension, said this morning that it has raised $20M in a Series B funding round. The round was led by MPM Capital, and also included prior investor ... READ MORE...
posted on Thursday, November 11, 2010
Ceregene Scores $11.5M
San Diego-based biopharmaceuticals firm Ceregene announced this morning that it has raised $11.5M in a Series D funding round. The round was co-led by Hamilton Bioventures and Alta Partners, and also included MPM Capital and Investor Growth... READ MORE...
posted on Thursday, November 11, 2010
Ambit Files For IPO
San Diego-based Ambit Biosciences, a firm discovering, developing and commercializing targeted small molecule therapeutics for treating cancer, has filed for an IPO, saying it is looking to raise up to $86.25M on the Nasdaq Global Market. T... READ MORE...
posted on Monday, November 8, 2010
Ambit Expands Board, Names Execs
San Diego-based Ambit Biosciences, a developer of small molecule treatments for cancer, said today that it has named Faheem Hasnain as its Chairman of the board, added Alan Fuhrman as its Chief Financial Officer, and promoted Chritopher Mor... READ MORE...
posted on Monday, November 8, 2010
Caldera Medical Gets Grant
Agoura Hills-based Caldera Medical, a developer of medical devices for the gynecology, urology and urogynecology markets, said this week that it has received two grants worth a total of $488,958 from the U.S. Department of the Treasury. Acc... READ MORE...
posted on Friday, November 5, 2010
Zogenix Sets Pricing Range, Offering Size In IPO
San Diego-based Zogenix has updated its S-1, saying this morning the firm intends to offer 6 million shares of its common stock on the Nasdaq Global Market as ZGNX. The firm also said it currently estimates the firm's initial offering price... READ MORE...
posted on Thursday, November 4, 2010
International Technidyne Acquired By Warburg Pincus, Merges With Nexus Dx
San Diego-based International Technidyne Corporation (ITC), a provider of blood testing devices, has been acquired by private equity firm Warburg Pincus, and also merged with venture backed San Diego firm Nexus Dx. According to ITC, a subsi... READ MORE...
posted on Thursday, November 4, 2010
PathCentral Gets $10M More
Irvine-based PathCentral, a provider of pathology services and software to community pathologists, said Tuesday that it has raised $10M in a Series B funding round. The round was led by Okapi Venture Capital, Arboretum Ventures, and Baird V... READ MORE...
posted on Tuesday, November 2, 2010
GenMark Diagnostics In Licensing Deal
Carlsbad-based GenMark Diagnostics, a developer of molecular diagnostic testing systems, said this morning that it has acquired a non-exclusive license to technology from Innogentics. The firm said the licesne covers Innogenetics' Hepatitis... READ MORE...
posted on Tuesday, November 2, 2010
Endologix Buys Nellix, Gets $15M Investment
Irvine-based Endologix, a developer of minimally invasive treatments for aortic disorders, said this morning that it has agreed to acquire Nellix, a developer of medical devices for treating abdominal aortic aneurysms (AAAs). Endologix said... READ MORE...
posted on Thursday, October 28, 2010
Regulus Therapeutics Gets $10M From Sanofi-Aventis
La Jolla-based Regulus Therapeutics reports today that it has received $10M in an equity investment from drug maker Sanofi-Aventis. The firm said the investment came as part of its strategic alliance with Sanofi-Aventis, which was signed Ju... READ MORE...
posted on Thursday, October 28, 2010
Phenomix Shuts Down, Says Report
San Diego-based Phenomix, a developer of diabetes drugs, has shut down, according to reports. The firm--which was developing drugs to help treat diabetes--apparently has laid off most of its staff, and is looking for a buyer for the assets.... READ MORE...
posted on Wednesday, October 27, 2010
KYTHERA Expands Board
Calabasas-based KYTHERA Biopharmaceuticals said this morning that it has added Francois Kress, the President and CEO of Prada, to its board of directors. KYTHERA, which develops products for the aesthetic medicine market, said that Kress ha... READ MORE...
posted on Wednesday, October 27, 2010
Response Genetics Loses COO
Los Angeles-based Response Genetics, a developer of molecular diagnostics tests for cancer, said Tuesday that it has lost its Chief Operating Officer, Michael B. McNulty. The reason for McNulty's departure was not announced. The firm said t... READ MORE...
posted on Wednesday, October 27, 2010
aTyr Pharma Nabs $23M
San Diego-based aTyr Pharma, a developer of biotherapeutics aimed at the blood, immune, and metabolism disorder areas, announced today that it has raised $23M in a Series C equity financing round. The round was led by Domain Associates, and... READ MORE...
posted on Tuesday, October 26, 2010
Clarient Acquired By GE Healthcare For $580M
Aliso Viejo-based Clarient, a developer of cancer diagnostic tools, is being acquired by GE Healthcare in a deal worth $580M. According to GE Healthcare, which is a unit of General Electric, it will pay $5.00 per common share or $20.00 per ... READ MORE...
posted on Friday, October 22, 2010
Minnow Medical Gets $4.7M
Laguna Hills-based Minnow Medical, a developer of treatments for peripheral vascular disease therapy, said said Wednesday that it has raised $4.7M in a combination of equity and convertible debt. According to the firm, it sold $3.2M in pref... READ MORE...
posted on Thursday, October 21, 2010
CLRS Technology Acquired By Solta Medical
Costa Mesa-based CLRS Technology, a developer of personal care products for treating acne, has been acquired. According to acquiring firm Solta Medical, it is acquiring CLRS for the payment of approximately $1.1M of debt, plus potential fut... READ MORE...
posted on Monday, October 18, 2010
Cogent's Ming Hsieh Gives Another $50M To USC
The University of Southern California announced Friday, in conjunction with the inauguration of new president C. L. Max Nikias, that Ming Hsieh, the founder of Monrovia-based COgent, has donated $50M to endow a new instute focused on nano-m... READ MORE...
posted on Saturday, October 16, 2010
Pathway Genomics Raises Additional Funding
San Diego-based Pathway Genomics, a provider of genetic testing services, has raised additional funding, according to the firm's legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Amount, details, and source of the new fundi... READ MORE...
posted on Thursday, October 14, 2010
Halozyme Therapeutics Chops 25 Percent
San Diego-based Halozyme Therapeutics, a firm developing biopharmaceuticals for the endocrinology, oncology, dermatology and drug delivery markets, said late Monday that it has cut its workforce by approximately 25 percent, as it says it is... READ MORE...
posted on Tuesday, October 12, 2010
Ligand Names New Board Member
San Diego-based Ligand Pharmaceuticals, a developer of a broad line of pharmaceuticals, said today that it has named Sunil Patel to its board of directors. Patel is Senior Vice President of Corporate Development for OncoMed Pharmaceuticals,... READ MORE...
posted on Friday, October 8, 2010
Synthetic Genomics, J. Craig Venter Spin Out New Vaccine Startup
La Jolla-based Synthetic Genomics and the J. Craig Venter Institute, the nonprofit genetic research organization of genetic sequencing pioneer J. Craig Venter, said today that they have formed a new company in San Diego, Synthetic Genomics ... READ MORE...
posted on Thursday, October 7, 2010
Ligand Sells Screening Technology
San Diego-based Ligand Pharmaceuticals announced today that it has agreed to sell its combinatorial compound library and screening technology, in a deal worth $1.8M. According to Ligand, it is selling the technology to Venenum Biodesign, LL... READ MORE...
posted on Thursday, October 7, 2010
LivHOME Targets Expansion Via Franchising
Los Angeles-based LivHOME, a venture backed provider of in-home care for seniors, said today that it has launched a franchising program. The firm--which is venture backed by Scale Venture Partners, Tullis Dickerson, and Kilne Hawkes--said t... READ MORE...
posted on Tuesday, October 5, 2010
Opthonix Sees $5.39M More
Vista-based Opthonix, a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M financing, according to a regulatory filing from the firm earlier this week. Details on the funding ha... READ MORE...
posted on Wednesday, September 29, 2010
Valeant Shareholders Approve Biovail Buyout, Despite Objections
Shareholders of Aliso Viejo-based Valeant Pharmaceuticals and Canadian firm Biovail have approved Valeant's acquisition by Biovail, despite objections from Biovail founder Eugene Melnyk and a a number of California state lawmakers. The deal... READ MORE...
posted on Monday, September 27, 2010
QAD Signs Nexus Dx
Santa Barbara-based QAD, the developer of enterprise resource planning software, said this morning that San Diego-based life sciences firm Nexus Dx has adopted its software. According to QAD, Nexus Dx is using QAD Enterprise Applications, i... READ MORE...
posted on Monday, September 27, 2010
Cylene Pharmaceuticals Gets $12M
San Diego-based Cylene Pharmaceuticals reported today that it has raised $12M in a financing round, from its existing investors, as it kicks off a Phase I clinical trial. The developer of treatments for multiple myeloma said the funding cam... READ MORE...
posted on Friday, September 24, 2010
Cytomx Gets $30M, But Plans Move North
Santa Barbara-based CytomX Therapeutics, a biotechnology firm developing antibodies, said this morning that it has raised $30M in a Series B funding round. The round was led by Third Rock Ventures, and also included the Roche Venture Fund. ... READ MORE...
posted on Thursday, September 23, 2010
A-Life Medical Acquired By UnitedHealth
San Diego-based A-Life Medical, a firm which developed software to help physicians to properly code the billing of medical procedures, has been acquired by a unit of UnitedHealth Group, the firms said Tuesday. According to Ingenix, the Unit... READ MORE...
posted on Wednesday, September 22, 2010
Valeant Plans Cash Payout, Following Biovail Merger
Aliso Viejo-based Valeant Pharmaceuticals, the specialty pharmaceuticals firm that is in the midst of a merger with Biovail, said today that it is planning a one time, special cash dividend of $16.77 per share, in conjunction with the merge... READ MORE...
posted on Wednesday, September 22, 2010
Interview with Scott Sangster, Health In Reach
Yesterday, there were a lots of startups who launched at the DEMO Fall event in Silicon Valley. One of the local firms that launched was Los Angeles-based Health In Reach (www.healthinreach.com). HealthInReach was founded by Scott Sangste... READ MORE...
posted on Wednesday, September 15, 2010
Health In Reach Launches Medical Scheduling Service
Los Angeles-based Health In Reach, a new startup founded by Scott Sangster, has launched its new service today at the DEMO Fall conference. Health In Reach is focused on helping patients find doctors, schedule appointments, and receive upfr... READ MORE...
posted on Tuesday, September 14, 2010
Kareo Gets $9.5M
Irvine-based Kareo, a developer of web-based medical billing software, announced today that it has raised $9.5M in an investment round. According to Kareo, the funding came from OpenView Venture Partners. The firm said the new funding will ... READ MORE...
posted on Monday, September 13, 2010
Valeant Sees Deeper Job Cuts
Aliso Viejo-based Valeant Pharmaceuticals is planning deeper cuts, after the firm's merger with Biovail, according to an email released by the firm via a regulatory filing Tuesday. According to Valeant, it now expects to cut 25 percent of i... READ MORE...
posted on Wednesday, September 8, 2010
NEXUS Completes REMP Sample Management Buy
Poway-based NEXUS Biosystems, a developer of automated sample management systems for the pharmaceuticals and biotech industry, said today that it has completed its acquisition of REMP AG of Switzerland, a developer of sample management syst... READ MORE...
posted on Wednesday, September 8, 2010
Zogenix Files For IPO
San Diego-based Zogenix, a developer of needle-free, delivery systems for the treatment of acute migraines and cluster headaches, has filed for a $90M IPO. The IPO is being underwritten by Wells Fargo Securities, Leerink Swann, Oppenheimer ... READ MORE...
posted on Tuesday, September 7, 2010
Somaxon In Commercial Availability
San Diego-based pharmaceuticals firm Somaxon Pharmaceuticals reports this morning that it is now in commercial availability of its Silenor compound in the United States. The firm said it has now implemented wholesale and retail stocking of ... READ MORE...
posted on Tuesday, September 7, 2010
Accumetrics Closes On $24M In Funding
San Diego-based Accumetrics, a developer of medical devices used to measure antiplatelet therapy, a technique used to prevent heart attack and stroke, said this morning that it has closed on a $24M funding round. The firm said the funding c... READ MORE...
posted on Wednesday, September 1, 2010
CEBIX Raises $14.0M
La Jolla-based Cebix, a developer of treatments for type 1 diabetic neuropathy, has raised $14.0M in a new funding round, according to a regulatory filing by the firm today. Details on the funding have not been announced by the company, how... READ MORE...
posted on Tuesday, August 31, 2010
DexCom Board Member Departs
San Diego-based DexCom, a developer of continuous glucose monitoring systems, said Monday afternoon that Donald A. Lucas has resigned from the firm's board of directors. Lucas is Founding Managing Member at RWI Group, which was an investor ... READ MORE...
posted on Tuesday, August 31, 2010
Otonomy Raises $38.5M
San Diego-based Otonomy, a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M in a Series B financing. The round was led by Novo Ventures and RiverVest Ventu... READ MORE...
posted on Monday, August 30, 2010
Finistere Ventures Targets New Fund
San Diego-based venture capital firm Finistere Ventures, which is focused on early stage medical devices and biotechnology investments, is in the midst of raising a new fund, Finistere Ventures II, according to VentureWire this week. No oth... READ MORE...
posted on Friday, August 27, 2010
GreatCall Expands Into Medication Reminders
Looking to capitalize on the firm's customer demographics, San Diego-based GreatCall, the operator of the Jitterbug easy-to-use cell phone, said today that it has rolled out a new "Medication Reminder" service. The company, which is venture... READ MORE...
posted on Tuesday, August 24, 2010
Enterprise Partners Re-Ups On Complete Genomics
San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics, Complete Genomics said today. The round was led by Sands Capital, and also included Es... READ MORE...
posted on Thursday, August 19, 2010
Life Technologies Buys Ion Torrent
Carlsbad-based Life Technologies, a developer of DNA sequencing technology, said Tuesday afternoon that it has agreed to buy Ion Torrent in a $375M deal. According to the firm, the cash and stock deal also includes up to $350M in additional... READ MORE...
posted on Tuesday, August 17, 2010
Cibus Global Finds $1.1M
San Diego-based Cibus Global, a developer of technology for engineering agricultural crops, has raised $1.16M in funding, according to a regulatory filing by the firm Tuesday. The funding appears to be part of an ongoing, $2.6M fundraising ... READ MORE...
posted on Tuesday, August 17, 2010
REVA Medical Looks To Australia For IPO
San Diego-based REVA Medical, a developer of stents used for treating coronary artery disease, has filed for an IPO in Australia. According to REVA, it is looking to raise up to $63M in an offering on the Australian Securities Exchange. REV... READ MORE...
posted on Monday, August 16, 2010
Toshiba Names Business Unit Exec
Tustin-based Toshiba America Medical Systems, the marketing, distribution, and services arm of Toshiba's diagnostic imaging systems group, said today that it has named Stuart Clarkson as Director of its MR Business Unit. Toshiba said Clarks... READ MORE...
posted on Thursday, August 12, 2010
CareFusion Cuts 700 Employees
San Diego-based CareFusion, a manufacturer of medical devices including pumps, patient identification systems, ventilators, surgical instruments, and more, said last night that it is cutting 700 jobs in a company-wide restructuring. The fir... READ MORE...
posted on Wednesday, August 11, 2010
Aspyra Acquired By Orion Healthcare Ventures
Westlake Village-based Aspyra said Monday that it has been acquired by Orion Healthcare Ventures LLC. The firm, which develops healthcare information technology products, did not disclose financial details of the acquisition. Orion Healthca... READ MORE...
posted on Tuesday, August 10, 2010
MabVax Gets $1.1M In STTR Grant
San Diego-based MabVax Therapeutics, a biotechnology firm focused on vaccine and antibody therapies for treating cancer, said today that it has received a $1.1M, Phase 2 Small Business Technology Transfer Program Award (STTR) from the Natio... READ MORE...
posted on Tuesday, August 10, 2010
XIFIN Names CFO
San Diego-based XIFIN, a developer of revenue cycle management software-as-a-service for the healthcare industry, said Monday that it has named Craig Kussman as Chief Financial Officer at the firm. Kussman has previously served at Breach Se... READ MORE...
posted on Tuesday, August 10, 2010
Life Technologies, UCSD Tie On Genomic Analysis Effort
Carslbad-based Life Technologies, a developer of genomic analysis technology, and the University of California at San Diego's Moores Cancer Center, said this morning that the two are collaborating on a research effort. According to the two,... READ MORE...
posted on Thursday, August 5, 2010
Concerro Names COO
San Diego-based Concerro, a developer of hospital workforce management software, said Tuesday that it has named Cindy Watson as Chief Operating Officer of the firm. Watson was most recently Vice President of Client Services for the firm. W... READ MORE...
posted on Wednesday, August 4, 2010
Althea Technologies Gets $17M In Venture Debt
San Diego-based Althea Technologies, a provider of contract development and manufacturing for the life sciences market, has raised $17M in debt funding, according to financing provider Hercules Technology Growth Capital. Use for the funding... READ MORE...
posted on Tuesday, August 3, 2010
Trius Therapeutics To Hit Markets Today In IPO
San Diego-based Trius Therapeutics is set to hit the markets today, after pricing its IPO last night. Trius will trade on the NASDAQ Global Market under the symbol TSRX. Trius, a biopharmaceuticals firm developing antibiotics, priced its IP... READ MORE...
posted on Tuesday, August 3, 2010
Trius Therapeutics Chops IPO Offering Price
San Diego-based Trius Therapautics has slashed its IPO offering price, saying today in a filing with the SEC that it will offer 10,000,000 shares of its common stock at $5.00 per share. The firm, which will list on the Nasdaq Global Market ... READ MORE...
posted on Monday, August 2, 2010
Conatus Pharmaceuticals Buys Idun Pharmaceuticals
San Diego-based Conatus Pharmaceuticals said Friday that it has acquired the Idun Pharmaceuticals subsidiary of Pfizer. Financial terms of the buy were not disclosed. According to Conatus Pharmaceuticals, it is focused on developing drugs f... READ MORE...
posted on Monday, August 2, 2010
Illumina Buys Helixis
San Diego-based Illumina said today it has launched a new, real-time PCR system for the genetic analysis market, and also revealed that it acquired Carlsbad-based Helixis, a developer of those real-time PCR systems. The deal was worth $70M ... READ MORE...
posted on Tuesday, July 27, 2010
BioIQ Ups Funding By $1.0M
Santa Barbara-based BioIQ, the provider of online wellness testing and related services for employees and their employers, has upped its latest round of funding to just over $1.0M, according to a regulatory filing from the firm today. Detai... READ MORE...
posted on Monday, July 26, 2010
Amgen Adds To Board
Thousand Oaks-based biotech giant Amgen said Thursday that it has named Ronald D. Sugar to the firm's board of directors. Sugar is the former Chairman of Northrop Grumman Corp, having served as Chairman and CEO of the defense firm from 2003... READ MORE...
posted on Friday, July 23, 2010
NEXUS Biosystems Buys Swiss Firm
Poway-based NEXUS Biosystems, a developer of automated sample management systems for the biopharmaceuticals industry, said Thursday that it has signed an agreement to acquire REMP AG, a Swiss-based firm which provides sample management syst... READ MORE...
posted on Friday, July 16, 2010
Amgen Names New CFO
Thousand Oaks-based biotech giant Amgen announced this morning that it has appointed Jonathan M. Peacock as Chief Financial Officer. Peacock replaces Michael A. Kelly, who has been acting CFO since May. According to Amgen, Peacock joins fro... READ MORE...
posted on Friday, July 16, 2010
Illumina Names VP
San Diego-based Illumina announced this morning that it has appointed Melina Cimler as Vp Quality and Regulatory Affairs. Cimler joins the firm from PandiaDx Consulting, and has also served at Beckman Coulter, Abbot Molecular, and Gen-Probe... READ MORE...
posted on Friday, July 16, 2010
Zogenix Gets $50M in Debt, Equity
San Diego-based Zogenix announced today that it has just raised $35M in debt, and $15M in equity funding. The developer of biopharmaceuticals said that the $35M in debt came from Oxford Finance Corporation and Silicon Valley Bank, and was s... READ MORE...
posted on Tuesday, July 13, 2010
Irvine Scientific Opens Second Facility In Japan
Santa Ana-based Irvine Scientific, a developer of medical devices for the cell culture and biopharmaceutical industry, said this morning that it has opened up a second facility, in Tokyo, Japan. The firm said the new facility will manufactu... READ MORE...
posted on Monday, July 12, 2010
Ceres Details Financing Round
Thousand Oaks-based Ceres, a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. The funding came from Artal Luxembourg, Ambergate Trust, Gimv, and other undisclosed ... READ MORE...
posted on Thursday, July 8, 2010
Uptake Medical Raises $17.5M
Seattle- and Irvine-based Uptake Medical, a developer of medical technologies for the treatment of lung disease, said today that it has completed a Series B financing round worth $17.5M. Uptake said the round was led by Maverick Capital, an... READ MORE...
posted on Wednesday, July 7, 2010
Illumina Expands Board
San Diego-based Illumina, a developer of life sciences tools and sequencers, said this morning that it has named Gerald Moller, Ph.D., to its board. Moller is an advisor at investment firm HBM Bio Ventures AG. Moller has previously served a... READ MORE...
posted on Wednesday, July 7, 2010
LenSx Acquired By Alcon
Aliso Viejo-based LenSx Lasers, a developer of laser technology used for cataract surgery, has been acquired by Alcon, Alcon said late Tuesday. According to Alcon, it will pay $361.5M in cash for LenSx shareholders, plus up to $382.5M in co... READ MORE...
posted on Tuesday, July 6, 2010
Illumina Names VP
San Diego-based Illumina announced this morning that it has named Nicholas J. Naclerio, Ph.D., as Senior Vice President, Corporate Development at the firm. Naclerio was the co-founder and executive chairman of Quanterix, and also has served... READ MORE...
posted on Friday, July 2, 2010
TargeGen Acquired By Sanofi-aventis
San Diego-based TargeGen, a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday.... READ MORE...
posted on Wednesday, June 30, 2010
Abraxis BioScience Acquired For $2.9 Billion
Los Angeles-based Abraxis BioScience, a developer of cancer treatments, is being acquired by Celegene Corporation in a deal worth $2.9 billion. According to Celegene, it will pay $58.00 in cash and 0.2617 shares of its common stock for Abra... READ MORE...
posted on Wednesday, June 30, 2010
AqueSys Gets $35M
Irvine-based AqueSys, a developer of medical devices for the treatment of glaucoma, said today that it has raised $35M in a Series C funding round. The round was led by Longitude Capital and Rho Ventures, and also included Accuitive Medical... READ MORE...
posted on Tuesday, June 29, 2010
Xencor In License With MorphoSys
Monrovia-based Xencor, the biopharmaceuticals firm headed by Dr. Bassil Dahiyat, has inked a licensing deal with German pharmaceuticals firm MorphoSys, Morphosys said over the weekend. Accordin to MorphoSys, it has gained an worldwide licen... READ MORE...
posted on Monday, June 28, 2010
Nereus Pharmaceuticals Rounds Up $20M More
San Diego-based Nereus Pharmaceuticals, a firm developing drugs for the treatment of lung cancer, said Tuesday that it has raised another $20M in funding and commitments from its venture backers. The new funding round was led by HBM Biovent... READ MORE...
posted on Wednesday, June 23, 2010
Spectrum Pharmaceuticals Names Chief Commercial Officer
Irvine-based Spectrum Pharmaceuticals, a biopharmaceuticals firm focused on oncology and hematology, said today that it has named James E. Shields as its Chief Commercial Officer. Shields was most recently with Teva Pharmaceuticals Industri... READ MORE...
posted on Wednesday, June 23, 2010
DexCom Names COO, CTO
San Diego-based DexCom, a developer of continuous glucose monitoring systems, said today that it has named Steven R. Pacelli as its Chief Operating Officer, and Jorge Valdes as Chief Technology Officer. Pacelli has been Chief Administrative... READ MORE...
posted on Tuesday, June 22, 2010
Valeant Merges With Biovail
Aliso Viejo-based pharmaceuticals firm Valeant said today that it has agree to merge with Biovail, a Toronto-based pharmaceuticals developer. According to the firms, the deal calls for Valeant stockholders to receive $16.77 in cash per shar... READ MORE...
posted on Monday, June 21, 2010
Gen-Probe Invests $50M In Pacific Biosciences
San Diego-based scientific instruments maker Gen-Probe has invested $50M in a Northern California firm developing DNA sequencing technology, Pacific Biosciences. According to the two firms, Gen-Probe made the investment as part of a larger ... READ MORE...
posted on Thursday, June 17, 2010
Cyntellect Names CEO
San Diego-based Cyntellect, a life sciences firm developing stem cell and other biopharmaceuticals products, said today that it has named Saiid Zarrabian as the firm's CEO. Zarrabian replaces Fred Koller, who becomes Chief Technology Office... READ MORE...
posted on Thursday, June 17, 2010
Prolacta Ties With Susan G. Komen for the Cure
Monrovia, California-based Prolacta Bioscience, the venture backed firm developing human milk fortifiers for premature infants, announced this morning that it will be donating funds to the Susan G. Komen for the Cure as part of its milk don... READ MORE...
posted on Tuesday, June 15, 2010
Cytori Gets $20M In Loan Facility
San Diego-based Cytori Therapeutics, a developer of medical devices and instruments for the cosmetic and reconstructive surgery market, announced today that it has received $20M in a loan facility. The facility came from GE Capital, Healthc... READ MORE...
posted on Monday, June 14, 2010
MP Biomedicals Buys New Zealand Firm
Santa Ana-based MP Biomedicals, a diversified manufacturer of life sciences products, said this morning that it has signed a definitive agreement to acquire New Zealand firm ICPbio International LTD, in an asset deal. ICPbio is a manufactur... READ MORE...
posted on Monday, June 14, 2010
AqueSys Snags $7.5M
Irvine-based AqueSys, a medical device firm which is working on a proprietary surgical device for the treatment of glaucoma, has raised $7.5M of a $35M funding round, according to a regulatory filing by the firm today. Source of the new fun... READ MORE...
posted on Friday, June 11, 2010
Otonomy Raises $10M
San Diego-based Otonomy, which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. According to Otonomy, the funding will go towards supporti... READ MORE...
posted on Friday, June 11, 2010
Otonomy Takes $10.5M
San Diego-based Otonomy, a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm. Source... READ MORE...
posted on Wednesday, June 9, 2010
Firm With Ties To UCI Gets Backing Of Iacocca Family
A Seattle-area firm, Kineta, with ties to two University of California, Irvine professors has scored funding support from the Iacocca Family Foundation, created by Lee A. Iacocca, the company said today. Kineta said that the Iacocca Family ... READ MORE...
posted on Monday, June 7, 2010
Arena Pharmaceuticals Raises $35.5M In PIPE
San Diego-based Arena Pharmaceuticals, a firm developing biopharmaceuticals, including a compound targeted at weight loss and weight management, said today that it is raising $35.5M in an equity investment from Deerfield Management. Publicl... READ MORE...
posted on Thursday, June 3, 2010
Life Technologies Invests in Synthentic Genomics
Carlsbad-based Life Technologies said Wednesday that it has made an equity investment in Synthetic Genomics, a firm commercializing synthetic genomic advances. Terms of the investment were not announced. Synthetic Genomics develops technol... READ MORE...
posted on Wednesday, June 2, 2010
Amgen Gets FDA Approval On Prolia
Thousand Oaks-based Amgen said Tuesday evening that it has received U.S. Food and Drug Administration (FDA) approval on its pRolia treatment of osteoporosis for postmenopausal women. The firm said the approval was based on its Phase 3 study... READ MORE...
posted on Wednesday, June 2, 2010
Altura Medical Scores $20M
San Clemente-based Altura Medical announced this morning that it has raised $20M in a Series A financing round. The firm said the funding was led by New Leaf Venture Partners, and also included Advanced Technology Ventures and SV Life Scien... READ MORE...
posted on Tuesday, June 1, 2010
Life Technologies Buys Majority Stake In Geneart
Carlsbad-based Life Technologies announced this morning that it has acquired a majority stake in Geneart AG, a synthetic biology company. The firm said it now owns approximately 74 percent of Geneart, after purchasing approximately 554,000 ... READ MORE...
posted on Friday, May 28, 2010
GenMark Chops IPO Offering Price
Pasadena-based Genmark Diagnostics, a maker of molecular diagnostics equipment, lowered its initial public offering price to between $6.00 and $7.00 per share yesterday, down from an earlier anticipated initial public offering price of betw... READ MORE...
posted on Friday, May 28, 2010
Valeant Completes Aton Pharma Buy
Aliso Viejo-based Valeant Pharmaceuticals said today that it has completed its acquisition of Aton Pharma, a specialty pharmaceuticals firm focused on ophthalmology and other drugs. The deal was worth $318M. Aton Pharma was based in lawrenc... READ MORE...
posted on Thursday, May 27, 2010
ReVision Optics Raises $35M
Lake Forest-based ReVision Optics, a firm developing implantable lenses for correcting vision, announced Tuesday that it has raised $35M. The round was led by ProQuest Investments, and also included Domain Associates, Canaan Partners, and I... READ MORE...
posted on Tuesday, May 25, 2010
ReVision Optics Sees $35M
Lake Forest-based ReVision Optics, a developer of implantable lenses for treating presbyopia, has received $35.0M in a new round of venture funding, according to a regulatory filing by the firm Tuesday. Details on the funding have not yet b... READ MORE...
posted on Tuesday, May 18, 2010
CareFusion Completes Medegen Buy
San Diego-based CareFusion, a provider of medical devices, said Monday that it has completed its $225M cash acquisition of Medegen, a developer of needleless access connectors for delivering intravenous medication to patients. The acquisiti... READ MORE...
posted on Tuesday, May 18, 2010
Halozyme Warns Baxter On Manufacturing Issues
San Diego-based Halozyme Therapeutics said over the weekend that it has delivered notice to Baxter Healthcare, that Baxter is in breach due to failure to provide its HYLENEX (hyaluronidase human injection) product per the firm's development... READ MORE...
posted on Monday, May 17, 2010
Enclarity Gets Investment From Emdeon
Aliso Viejo-based Enclarity, a developer of healthcare information solutions, recently received an investment from Nashville, Tennessee-based Emdeon. Financial terms of the investment were not announced, however, Emdeon said that the minori... READ MORE...
posted on Thursday, May 13, 2010
Sequent Medical Raises $15.6M
Aliso Viejo-based Sequent Medical, a firm focused on medical devices for treating neurovascular disease, said Thursday that it has raised $15.6M in a Series B funding round. The funding was led by Domain Associates, and also included Versan... READ MORE...
posted on Thursday, May 13, 2010
Astute Medical Finds $26.5M
San Diego-based Astute Medical, a developer of biomarker-based medical diagnostics products, has raised $26.5M in a Series B funding round, the firm said yesterday. The round was co-led by Domain Associates and Delphi Ventures. According to... READ MORE...
posted on Tuesday, May 11, 2010
Livestrong Looks To USC For Chief Medical Advisor
Santa Monica-based LIVESTRONG.COM, the online health information site run by Demand Media and the Lance Armstrong Foundation, said today that it has named Dr. Leslie Anne Saxon as its Chief Medical Advisor. Saxon is Professor of Medicine, C... READ MORE...
posted on Tuesday, May 4, 2010
Canon Communications Buys Pharmaceuticals Blog Pharmalot
Los Angeles-based Canon Communications, a publisher and trade show operator serving the pharmaceutical industry, said Monday that it has acquired Pharmalot, a blog focused on news and information in the pharmaceutical industry. Financial te... READ MORE...
posted on Monday, May 3, 2010
ADVENTRX Pharmaceuticals Gets $19.2M
San Diego-based ADVENTRX Pharmaceuticals, a publicly held developer of cancer treatments, said today that it is in a private placement where it will receive $19.2M in a Series F convertible preferred stock round. Source of the new funding w... READ MORE...
posted on Monday, May 3, 2010
InTouch Health Gets $10M, Eyes Public Markets
Santa Barbara-based InTouch Technologies, a developer of remote presence systems used for the healthcare industry, announced today that it has raised $10M in a private placement. The round came from Beringea, via its InvestMichigan! Growth ... READ MORE...
posted on Monday, May 3, 2010
Althea Technologies Buys Altus Pharmaceuticals
San Diego-based Althea Technologies, a contract development and manufacturing firm for the biopharmaceuticals industry, said today that it has acquired the assets and IP portfolio of Altus Pharmaceuticals. Financial terms of the deal were n... READ MORE...
posted on Monday, May 3, 2010
Illumina Names Two VPs
San Diego-based Illumina, a developer of gene sequencing tools, said today that it has named Elizabeth Brady as the firm's Vice President, Global Supply Chain, and Emily S. Winn-Deen, Ph.D., as its Vice President, Diagnostics Development. B... READ MORE...
posted on Friday, April 30, 2010
Schrodinger Gets Investment From Bill Gates
Schrodinger, a firm focused on computational drug design for the pharmaceuticals and biotechnology research industry, announced today that Bill Gates--through his investment firm, Cascade Investment--has invested in the company. The firm, w... READ MORE...
posted on Thursday, April 29, 2010
Amgen Names President, COO
Thousand Oaks-based Amgen announced this morning that it has named Robert A. Bradway as the firm's President and Chief Operating Officer. Bradway has been at Amgen since 2006, and was most recently Executive Vice President and Chief Financi... READ MORE...
posted on Tuesday, April 27, 2010
KYTHERA Biopharmaceuticals Names VP
Los Angeles-based Kythera Biopharmaceuticals, which is developing aesthetic medicine products, said today that it has named Pierre J.G. Corin as the firm's Vice President, Global Clinical Operations. Corin joins the firm from Allergan Medic... READ MORE...
posted on Tuesday, April 27, 2010
Aragon Pharmaceuticals Raises $22M
San Diego-based Aragon Pharmaceuticals, a developer of treatments for hormonally driven cancers, said today that it has raised $22M in a Series B funding. The funding came from Aisling Capital, OrbiMed Advisors, and the Column Group. As par... READ MORE...
posted on Thursday, April 22, 2010
Valeant Buys Brazilian Pharmaceuticals Firm
Aliso Viejo-based Valeant Pharmaceuticals announced today that it has entered into a binding agreement to acquire a pharmaceuticals firm located in Brazil, in a deal worth approximately $56M (97 million Brazilian reals). According to Valean... READ MORE...
posted on Wednesday, April 21, 2010
CardioPolymers Adds $1.35M
Laguna Hills-based CardioPolymers, a developer of an implantable device for treating congestive heart failure, has added $1.35M to its venture funding, according to numbers from the latest PricewaterhouseCoopers/NVCA quarterly venture capit... READ MORE...
posted on Tuesday, April 20, 2010
Sotera Wireless Raises $10.75M
San Diego-based Sotera Wireless, a developer of patient monitoring technology, announced Monday afternoon that it has raised $10.75M in a strategic investment round. The round was led by West Family Holdings, LLC, and also included prior in... READ MORE...
posted on Monday, April 19, 2010
AltheaDx Raises $6M
San Diego-based AltheaDx, a developer of molecular diagnostics products, has raised $6M in a Series A round, the firm revealed today. The firm said the round was led by Telegraph Hill Partners. AltheaDx is focused on developing diagnostic t... READ MORE...
posted on Tuesday, April 13, 2010
Sotera Wireless Lands $10.7M
San Diego-based Sotera Wireless, a developer of wireless vital signs management product, has raised $10.7M as part of an ongoing, $15.0M funding round, accoridng to a regulatory filing today. Source of the new funding was not disclosed. The... READ MORE...
posted on Monday, April 12, 2010
Amplyx Pharmaceuticals Gets $1.5M
San Diego-based Amplyx Pharmaceuticals announced Thursday that the firm has raised $1.5M in a Series A funding round. According to the firm, the round came from Golden Seeds, a nationwide angel group investing in women-led companies, with p... READ MORE...
posted on Friday, April 9, 2010
NexMed Adds Execs
San Diego-based NexMed, a specialty contract research organization, announced earlier this week that it has named Terry Ladd as Vice President of Business Development at its Bio-Quant subsidiary, and Richard Martin as Vice President of Chem... READ MORE...
posted on Friday, April 9, 2010
Fate Therapeutics Acquires Verio Therapeutics
San Diego-based Fate Therapeutics, a developer of stem cell therapeutics, announced this morning that it is in a definitive agreement to acquire Canadian biotechnology firm Verio Therapeutics. Financial terms of the acquisition were not dis... READ MORE...
posted on Thursday, April 8, 2010
Accelrys, Symyx In Merger
San Diego-based Accelerys and Santa Clara-based Symyx announced this morning that the two are in a all-stock merger to create a new, scientific information software firm. The firms said that Symyx shareholders will receive 0.7802 shares of ... READ MORE...
posted on Monday, April 5, 2010
CareFusion Acquires Medegen For $225M
San Diego-based CareFusion, a firm that develops a wide range of medical devices, said today that it is paying $225M in cash for Ontario, California-based Medegen. Medegen develops needleless access valves and disposable IV sets that are us... READ MORE...
posted on Monday, April 5, 2010
Reverse Medical Raises $14M
Irvine-based Reverse Medical Corporation, a developer of microcatheters for treating neurovascular disorders, announced today that it has raised $14M in a Series B funding round. The firm said that the new funding came from Wexford Capital,... READ MORE...
posted on Tuesday, March 30, 2010
Cynvenio Biosystems Names VPs
Westlake Village-based Cynvenio Biosystems announed this morning that the firm has appointed two new VPs. According to Cynvenio, it has added David J. Sauvageau as the firm's Vice President, Engineering and Product Development, and Dr. Paul... READ MORE...
posted on Monday, March 29, 2010
Response Genetics Loses CFO
Los Angeles-based Response Genetics, a firm developing molecular diagnostic tests for cancer, announced this morning that its Chief Financial Officer, Thomas Stankovich, has resigned. The firm said that Stankovich resigned to "pursue other ... READ MORE...
posted on Monday, March 29, 2010
Cyntellect Raises $3.0M
San Diego-based Cyntellect, a developer of cytometry equipment, has raised $3.0M in a new funding round, according to a regulatory filing from the firm earlier this week. Details on the funding have not been disclosed by the company. Cyntel... READ MORE...
posted on Thursday, March 25, 2010
Genomatica Raises $15M
San Diego-based Genomatica, a developer of chemical processes based on bio-manufacturing, has raised $15M in a Series C funding round, the firm announced today. According to the firm, the new funding was led by TPG Biotech, and also include... READ MORE...
posted on Thursday, March 25, 2010
Gc-Free Raises $700K
Vista-based Gc-Free, a firm developing diagnostic tools to predict risks of colon, prostate, breast and other cancers, has raised $700,000 in an equity funding, according to a regulatory filing by the firm today. Source of the funding was n... READ MORE...
posted on Monday, March 22, 2010
Elcelyx Therapeutics Gets $1.2M
San Diego-based Elecelyx Therapeutics, a stealth mode biotech firm, has raised $1.2M in a funding round, which includes Morgenthaler Ventures, according to a regulatory filing this week. Details on the funding have not been announced by the... READ MORE...
posted on Friday, March 19, 2010
Valeant Buys Brazilian Firm
Aliso Viejo-based Valeant Pharmaceuticals announced today that it is in an agreement to buy a Brazilian manufaturer of branded, generic and over the counter pharmaceuticals. According to Valeant, the deal is worth approximately $28M. Valean... READ MORE...
posted on Friday, March 19, 2010
Genmark Diagnostics Files For IPO
Pasadena-based Genmark Diagnostics, a developer of a diagnostic biomarker detection system, has filed for an IPO, saying it is looking to raised up to $46.0M in an IPO on the NASDAQ Global Market. The firm said it is looking to trade as GNM... READ MORE...
posted on Friday, March 19, 2010
Isis Gets $6M From Bristol-Myers Squibb
Carlsbad-based Isis Pharmaceuticals, a firm developing antisense drugs for treating cardiovascular, metabolic and severe neurodegenerative diseases, and cancer, said this morning it has earned $6M in a milestone payment from Bristol-Myers S... READ MORE...
posted on Monday, March 8, 2010
Enigma Diagnostics Sets Up Shop In San Diego
Oxford, England-based Enigma Diagnostics, a molecular diagnostics firm, said today that it has opened up a new, regional headquarters in San Diego. Enigma said the new, 17,000 sq. ft. office is in the Sorrento Valley, where it will house sa... READ MORE...
posted on Thursday, March 4, 2010
La Jolla Pharmaceutical Dropped From Nasdaq
San Diego-based La Jolla Pharmaceuticals, the failed biopharmaceuticals firm which was previously developing treating lupus renal disease, reported today that it has received notification from the Nasdaq that it will be delisted from the ma... READ MORE...
posted on Wednesday, March 3, 2010
Valeant Links With Spear Pharmaceuticals
Aliso Viejo-based Valeant Pharmaceuticals said today that it has entered into an agreement with Spear Pharmaceuticals, where the firm will commercialize a cream used to reduce wrinkles and fade irregular pigmentation due to sun damage. Vale... READ MORE...
posted on Monday, March 1, 2010
Trius Therapeutics Sets IPO Pricing Range
San Diego-based Trius Therapeutics, which is looking to IPO on the Nasdaq as TSRX, indicated in a filing today that it is looking to price its IPO at between $12.00 and $14.00 per share. The firm's IPO is being underwritten by Credit Suiss... READ MORE...
posted on Thursday, February 25, 2010
Toshiba America Medical Names Marketing VP
Tustin-based Toshiba America Medical Systems, a manufacturer of diagnostic imaging systems for the healthcare market, said today that it has named Doug Ryan as Vice President, Marketing and Strategic Development, heading up the firm's strat... READ MORE...
posted on Tuesday, February 23, 2010
Quidel Completes Diagnostic Hybrids Acquisition
San Diego-based Quidel, a developer of medical diagnostic tests, said Friday that it has completed its $130M acquisition of Diagnostic Hybrids. Diagnostic Hybrids was located in Athens, Ohio, and develops in-vitro diagnostic assays used by ... READ MORE...
posted on Monday, February 22, 2010
TriTech Software Buys Health Care Technology Firm
San Diego-based TriTech Software Systems, a developer of public safety and other software for law enforcement, fire and emergency management services agencies, said Thursday that it has entered into an agreement to acquire Ortivus North Ame... READ MORE...
posted on Thursday, February 18, 2010
Tioga Pharmaceuticals Riases $18M
San Diego-based Tioga Pharmaceuticals said today that it has raised $18M in a new equity funding. The funding came from Forward Ventures, New Leaf Venture Partners, BB Biotech Ventures, and Genesys Capital Partners. According to Tioga, the ... READ MORE...
posted on Wednesday, February 17, 2010
NexMed Gets $2.7M In Private Placement
San Diego-based NexMed, a clinical research organization focused on in vitro and in vivo pharmacology services, said earlier this week that it raised $2.3M in a private placement. Name of the investors were not disclosed. The firm said the ... READ MORE...
posted on Friday, February 12, 2010
Quality Systems Buys Opus Healthcare Solutions
Irvine-based Quality Systems, which develops healthcare information systems, said today that it is in an agreement to acquire Opus Healthcare Solutions, a provider of web-based, clinical information systems. Financial details of the buy wer... READ MORE...
posted on Thursday, February 11, 2010
UCLA Looks To Tap Social Networks In Teen Health Effort
The UCLA School of Public Health is looking to tap into the power of social networks, in an attempt to encourage adolescents from 13 to 17 to take better care of their health. According to health care insurer Health Net and UCLA, the two ar... READ MORE...
posted on Wednesday, February 10, 2010
Xencor Names Baracchini Business Head
Monrovia-based Xencor, a developer of antibody discovery technology, said this morning that it has named Edgardo Baracchini, Ph.D., as Chief Business Officer at the company. Baracchini joins the firm from Metabasis Therapeutics, where he wa... READ MORE...
posted on Tuesday, February 9, 2010
PatientSafe Nabs $30M
San Diego-based PatientSafe Solutions, a developer of software and bar code systems used for management of patient and workflow management in hospitals, has reported raised $30M in a new round of funding. The funding was first reported by V... READ MORE...
posted on Monday, February 8, 2010
OrthAlign Gets $5.16M
Laguna Beach-based OrthAlign, a developer of medical devices for computer assisted surgery, has raised $5.16M in a Series A-2 funding round. Source of the funding was not announced by the firm, however, the firm has previously raised capita... READ MORE...
posted on Monday, February 8, 2010
Tragara Pharmaceuticals Snags $5M
San Diego-based Tragara Pharmaceuticals, a developer of biopharmaceuticals aimed at cancer and inflammation treatments, has raised another $5M in a funding round, according to a regulatory filing by the firm last week. The filing indicates... READ MORE...
posted on Monday, February 8, 2010
Life Technologies Completes Mass Spectrometry Business Sale
Carlsbad-based Life Technologies, a manufacturer of scientific equipment to the life sciences industry, has completed its sale of its mass spectrometry business to Danaher in a deal worth $450M in cash, the firm announced this morning. The... READ MORE...
posted on Monday, February 1, 2010
Abraxis Plans Spinoff, Names Execs
Los Angeles-based Abraxis BioScience confirmed this morning that it is still planning on a spinoff of its Abraxis Health division this year, and has named a number of executives as part of the effort. According to Abraxis, it has named Bruc... READ MORE...
posted on Thursday, January 28, 2010
Neomend Raises $30M
Irvine-based Neomend, a developer of sealants for the surgical market, announced this morning that it has raised $30M in a Series D funding round. Neomend said the round was led by Clarus Ventures, which contributed $17M of the total round.... READ MORE...
posted on Wednesday, January 27, 2010
Elevation Pharmaceuticals Gains $30M
San Diego-based Elevation Pharmaceuticals, a biopharmaceuticals firm developing treatments for repiratory diseases, said Thursday that it has closed on $30M of Series A funding. The funding came from Canaan Partners, TPG Growth, Care Capita... READ MORE...
posted on Thursday, January 21, 2010
US Healthworks Gains $175M
Valencia-based U.S. HealthWorks, an operator of occupational health care centers, said today that it has raised $175M in a combination of debt and equity. The firm said the funding will go towards its growth and acquisition strategy. The fu... READ MORE...
posted on Wednesday, January 20, 2010
Amgen Donates $2M To Haiti Earthquake Relief
Thousand Oaks-based Amgen said Thursday that it is donating $2M to Haiti relief efforts, as well as encourage its staff to contribute their own funds to organizations aiding in relief and rebuilding efforts in the country. According to Amge... READ MORE...
posted on Friday, January 15, 2010
Aliva Pharmaceuticals Raises $12.87M
Pasadena-based Aliva Pharmaceuticals, a firm developing animal systems for predicting human drug profiles, has raised $12.87M in funding, according to a recent regulatory filing by the firm. Source of the new funding was not disclosed. Acco... READ MORE...
posted on Thursday, January 14, 2010
SEDLine Gets Investment, Acquires Hospira Unit
Irvine-based SEDLine said today that it has acquired Hospira's brain function monitoring business, and scored an equity investment from Masimo. Financial details of the acquisition were not disclosed by the firm. According to SEDline, the f... READ MORE...
posted on Tuesday, January 12, 2010
VentiRx Gets $25M In Series A Extension
San Diego-based biopharmaceuticals firm VentiRx Pharmaceuticals said today that the firm has raised $25M in a Series A extension round. The firm, which is developing treatments for cancer, respiratory, and inflammatory disease, said the rou... READ MORE...
posted on Tuesday, January 12, 2010
Cynvenio Biosystems Gets Nearly $2M
Westlake Village-based Cynvenio Biosystems, a developer of high speed, bioseparation instruments for the life sciences market, has raised $1.96M in a Series B funding round, according to a regulatory filing by the firm today. Source of the ... READ MORE...
posted on Monday, January 11, 2010
Advanced Cardiac Therapeutics Raises $5M
Laguna Beach-based Advanced Cardiac Therapeutics, which develops advanced cardiac ablation systems, said this morning that it has raised $5M in a Series B funding. According to the firm, the funding was led by NBGI Ventures. The firm said t... READ MORE...
posted on Monday, January 11, 2010
Tandem Diabetes Nabs $31M
San Diego-based Tandem Diabetes, a developer of insulin pumps, has raised another $31.0M in funding, bring its current funding round to $52.3M, according to a regulatory filing by the firm lsat week. Source of the new funding was not disclo... READ MORE...
posted on Monday, January 11, 2010
Zynx Health Ties With MEDITECH
Los Angeles-based Zynx Health, a provider of clinical decision support systems for the healthcare industry, announced this morning that it has tied with IT healthcare provider MEDITECH, to offer a package addressing the American Recovery an... READ MORE...
posted on Monday, January 11, 2010
Quidel Buys Diagnostic Hybrids
San Diego-based Quidel, a developer of diagnostic tests, said today that it is in a definitive agreement to acquired Diagnostic Hybrids, a manufacturer of in-vitro diagnostic assays, in a deal worth approximately $130M in cash. According to... READ MORE...
posted on Monday, January 11, 2010
Inovio Taps Merck For Chief Medical Officer
San Diego-based Inovio Biomedical said this week that it has tapped a Merck veteran for its new Chief Medical Officer. According to Inovio, it has hired on mark L. Bagarazzi, M.D>, as Chief Medical Officer heading up worldwide clinical deve... READ MORE...
posted on Friday, January 8, 2010
Traversa Names Research VP
San Diego-based Traversa Therapeutics, a biopharmaceuticals firm developing RNA interference (RNAi) technology, said earlier this week that it has named Curt W. Bradshaw as Vice President of Research and Development. Bradshaw joins the firm... READ MORE...
posted on Friday, January 8, 2010
Marlin Equity Partners Buys Life Sciences Software Firm
Los Angeles-based private equity firm Marlin Equity Partners has acquired Pennsylvania-based Liquent, a developer of software and services for the life sciences industry, from Thomson Reuters. Financial details of the deal were not disclose... READ MORE...
posted on Thursday, January 7, 2010
Christie Acquires Luminetx
Cypress-based Christie Digital Systems, a developer of digital display systems, said Wednesday morning that it has acquired substantially all of the assets of Luminetx, a developer of medical devices used for detecting and mapping veins in ... READ MORE...
posted on Wednesday, January 6, 2010
Ambit Deal With Astellas Pharma Worth As Much As $350M
San Diego-based Ambit Biosciences inked a deal Friday with Astellas Pharma Inc., where Astellas will pay the firm $40M in cash, and up to $350M in pre-commercialization milestones, in a joint partnership to develop and commercialize Ambit's... READ MORE...
posted on Monday, December 21, 2009
Xencor Gets Milestone Payment
Monrovia-based Xencor, a developer of antibody engineering technology, reported today that the firm has received a milestone payment from Pfizer, as part of the firm's antibody technology license agreement with Pfizer. Amount of the payment... READ MORE...
posted on Wednesday, December 16, 2009
Amgen Licenses Rights For Diabetes Drug
Thousand Oaks-based Amgen and Colorado-based Array BioPharma announced Monday evening that Amgen is licensing the exclusive worldwide rights to Array's compounds for treating Type 2 diabetes, in a deal worth $60M plus additional contingent ... READ MORE...
posted on Tuesday, December 15, 2009
Calixa Therapeutics Acquired By Cubist Pharmaceuticals, In Big Win For Domain
San Diego-based Calixa Therapeutics, a biopharmaceuticals firm developing antibiotics to treat multi-drug resistant organisms, has been acquired by Cubist Pharmaceuticals, a Massachusetts-based biotherapeutics firm. The deal was worth $92.5... READ MORE...
posted on Monday, December 14, 2009
Pfenex Spins Out From Dow Chemical With $24M
San Diego-based Pfenix, a new startup focused on biotechnology technology for producing proteins, has spun out of Dow Chemical Company, Pfenex said this week. As part of the spinout, the firm has received $24M in a Series A funding round. T... READ MORE...
posted on Thursday, December 10, 2009
EVOFEM Gains $25M
San Diego-based EVOFEM, a firm developing feminine hygiene products, said today that it has raised $25M in a private equity investment. Name of the investor was not disclosed. EVOFEM--which was formerly known as Instead Healthcare--is devel... READ MORE...
posted on Tuesday, December 8, 2009
Zogenix Ups Series B To $71M
San Diego-based Zogenix, a pharmaceuticals firm developing neuroscience disorders and pain treatments, said Monday that it has closed on $35M in a second tranche of Series B funding, bringing the firm's Series B to a total of $71M. The firm... READ MORE...
posted on Monday, December 7, 2009
Nexus Biosystems Acquires Aurora Biotechnologies
Poway-based NEXUS Biosystems, a developer of automated sample management systems for the biotech industry, announced this morning that it has acquired Carlsbad-based Aurora Biotechnologies, a developer of microplate products used for sample... READ MORE...
posted on Monday, December 7, 2009
Somaxon Gets Rejection From FDA
San Diego-based Somaxon Pharmaceuticals, a developer of a drug for the treatment of insomnia, reported this morning that it has received a response from the U.S. Food and Drug Administration on its NAD for Silenor, the firm's treatment of i... READ MORE...
posted on Monday, December 7, 2009
Xencor Names Chairman
Monrovia-based Xencor, a developer of biotherapeutics, said today that it has named Bruce Carter, Ph.D., most recently the Chief Executive Officer of ZymoGenetics, as Chairman of the firm's board of directors. Carter has also served as Corp... READ MORE...
posted on Monday, December 7, 2009
Salk Insitute Adds VC To Board
La Jolla-based Salk Institute for Biological Studies, known for its life science research, disclosed this morning that the firm has added venture capitalists Fred Dotzler to its board of trustees. The institute said that Dotzler, co-founder... READ MORE...
posted on Thursday, December 3, 2009
Xencor Licenses Technology To Centocor
Monrovia-based Xencor, a developer of biotherapeutics technology to improve antibodies, said this morning that it has licensed its Fc engineering technology to Centocor Research & Development, Inc. Financial details of the license were not ... READ MORE...
posted on Monday, November 30, 2009
NextImage Medical Gains $5M
San Diego-based NextImage Medical, a provider of radiology services to the worker's comp market, said Tuesday that it has raised $5M in a Series A funding round. The round was led by Chrysalis Ventures. NextImage said the funding will go to... READ MORE...
posted on Tuesday, November 17, 2009
Fate Therapeutics Raises $30M
La Jolla-based Fate Therapeutics is reporting this morning that it has raised $30M in a Series B financing round. The firm, which develops stem cell therapies, said the funding was led by OVP Venture Partners, and included Astellas Venture ... READ MORE...
posted on Monday, November 16, 2009
Cyntellect Raises $15.5M
San Diego-based Cyntellect, a developer of products for the biotech industry, has raised $15.5M, according to a regulatory filing from the firm this week. The funding is part of an ongoing, $18.6M fundraising effort, and includes both equit... READ MORE...
posted on Thursday, November 12, 2009
Altair Therapeutics Raises $17M
San Diego-based Altair Therapeutics said Wednesday afternoon that it has raised $17M in a financing round. According to the firm, the round was led by Domain Associates, and also included AgeChem Venture Fund; Thomas, McNerney & Partners; F... READ MORE...
posted on Wednesday, November 11, 2009
Life Technologies Buys BioTrove
Carlsbad-based Life Technologies said today that it has signed a definitive agreement to acquire BioTrove, a developer of a high throughput gene expression and genotyping analysis system. Financial details of the acquisition were not disclo... READ MORE...
posted on Tuesday, November 10, 2009
Advanced Bionics Acquired By Sonova
Valencia-based Advanced Bionics, a manufacturer of cochlear implants, said Monday that it has entered into a definitive merger agreement with Sonova Holdings AG. Financial details of the acquisition were not announced. According to Advance... READ MORE...
posted on Monday, November 9, 2009
Trius Therapeutics Files For IPO
San Diego-based Trius Therapeutics has filed for an IPO, saying Friday that it is looking to raise $86.25M in an offering on the Nasdaq Global Market. According to the firm's filing, it has applied to trade under the symbol TSRX. The IPO is... READ MORE...
posted on Monday, November 9, 2009
Abraxis Health Expands In Arizona
Los Angeles-based Abraxis Health, the personalized healthcare division of Abraxis BioScience, said this morning that it is expanding in Arizona, and will open up a new biopharmaceuticals manufacturing plant in Phoenix. Abraxis said the plan... READ MORE...
posted on Thursday, November 5, 2009
Accenx Acquired By Initiate Systems
Irvine-based Accenx Technologies, a provider of health information exchange software, has been acquired by Initiate Systems, a data management firm based in Chicago. Financial terms of the deal were not released. According to Initiate, the ... READ MORE...
posted on Tuesday, November 3, 2009
Amgen Sued By New York, 14 Other States
Thousand Oaks-based biotech giant Amgen is the subject of a lawsuit being filed by New York Attorney General Andrew M. Cuomo, along with 14 other states, claiming that the biotech firm created a kickback scheme to boost drug sales. Accordin... READ MORE...
posted on Friday, October 30, 2009
Verdezyne Raises $2.96M
Carlsbad-based Verdezyne, which is developing technology to improve the fermentation process for biofuels, has raised $2.96M as part of a funding round, according to a regulatory filing from the firm Thursday afternoon. According to the fil... READ MORE...
posted on Friday, October 30, 2009
Abraxis Founder Pledges $100M To Reopoen MLK Jr. Hospital
Patrick Soon-Shiong, the billionaire founder of Abraxis Bioscience, has committed $100M in underwriting guarantees to reopen Martin Luther King, Jr. hospital (MLK), his foundation announced this week. According to the Chan Soon-Shiong Famil... READ MORE...
posted on Friday, October 30, 2009
One Recovery Raises $1.49M
Del Mar-based One Recovery, an online community site providing support for people recovering from addiction, has raised $1.49M in a funding round, according to a filing from the firm this week. According to the filing, the funding comes as ... READ MORE...
posted on Thursday, October 29, 2009
Helixis Bumps Funding To $7.3M
Carlsbad-based Helixis, a developer of nucleic acid analysis tools, has upped its recent funding round to $7.3M, according to a filing from the firm this week. The funding is a continuation of a $10.0M venture round which the firm has been ... READ MORE...
posted on Wednesday, October 28, 2009
Aspyra To Delist Stock
Westlake Village-based Aspyra said Tuesday afternoon that the firm is voluntarily delisting its common stock from the AMEX. The firm, which is listed at APY, said it intends to deslist due to limited trading in its common stock, the costs o... READ MORE...
posted on Wednesday, October 28, 2009
Ligand Buys Metabasis
San Diego-based biopharmaceuticals firms Ligand Pharmaceuticals and Metabasis Therapeutics announced this morning that Ligand is acquiring Metabasis, in a deal worth $3.2M in cash plus rights to receive payments from any royalties or licens... READ MORE...
posted on Tuesday, October 27, 2009
Ceres Gets $4.9M Grant From DOE
Thousand Oaks-based Ceres, a developer of energy crops for the biofuels energy, has landed $4,989,144 in a grant from the Department of Energy, as part of a $151M effort to fund energy breakthroughs. According to the DOE, the funding--part ... READ MORE...
posted on Monday, October 26, 2009
Allergan Wins Patent Suit
Irvine-based Allergan is reporting this morning that it has won a patent infringement case against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. in the US District Court for the District of Delaware. Allerga... READ MORE...
posted on Monday, October 26, 2009
Kythera Gets $10M More
Calabasas-based Kythera Biopharmaceuticals, a developer of aesthetic medicine products, has added $10M more in new funding. The new funding came to light in this week's PricewaterhouseCoopers/NVCA MoneyTree report. No details on the funding... READ MORE...
posted on Friday, October 23, 2009
Pathology Inc. Gets Debt Funding
Torrance-based Pathology Inc., a provider of pathology and molecular diagnostics services, has scored both a term loan and revolving line of credit from ORIX Venture Finance, ORIX said Wednesday. Terms and amount of the funding were not dis... READ MORE...
posted on Wednesday, October 21, 2009
Orqis Medical Assets Go On The Block
The physical assets of Lake Forest-based Orqis Medical, a venture backed firm which was developing treatments for congestive heart failure, are slated to go up for auction next week, according to auctioneer CowanAlexander. According to Cowa... READ MORE...
posted on Wednesday, October 21, 2009
U.S. Dermatology Gets Investment
Irvine-based U.S. Dermatology Medical Management, a provider of healthcare services for skin cancer treatment and other dermatological conditions, has scored an investment from Los Angeles-based Vicente Capital Partners, Vicente said today.... READ MORE...
posted on Wednesday, October 21, 2009
Vertos Medical Raises $15.5M
Aliso Viejo-based Vertos Medical, a developer of medical devices for treating lumbar spinal stenosis, announced this morning that it has raised $15.5M in a Series D funding. The round was led by new investor ONSET Ventures, with participati... READ MORE...
posted on Tuesday, October 20, 2009
Amgen Gets Delay On Osteoporosis Treatment
The Food and Drug Adminstration has delayed an approval of Thousand Oaks-based Amgen's osteoporosis denosumab, the firm said Monday, in order to seek more information. According to Amgen, the FDA has requested that the firm include further ... READ MORE...
posted on Monday, October 19, 2009
Veredezyne Gets $1.7M Grant
Carlsbad-based Veredezyne--which was formerly known as CODA Genomics--said today that it has received a $1.7M grant from the National Institute of Allergy And Infectious Diseases (NIAID). The firm said the grant, which lasts for 1.5 years, ... READ MORE...
posted on Monday, October 19, 2009
Gen-Probe Buys Molecular Testing Firm
San Diego-based Gen-Probe said Tuesday that it has signed a definitive agreement to acquire Prodesse, a provider of molecular testing for influenza and other infection diseases. The deal is worth $60M in cash, with provision to increase the... READ MORE...
posted on Wednesday, October 7, 2009
Cyntellect Expands In Europe
San Diego-based Cyntellect, a developer of scientific equipment for the life science and stem cell research market, reported today that it has opened up a new European headquarters in the U.K. The firm said the firm now has a team of sales,... READ MORE...
posted on Wednesday, October 7, 2009
Accumetrics Raises $16.5M
San Diego-based Accumetrics said today that it has raised $16.5M in new capital. The funding round came from Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Pa... READ MORE...
posted on Tuesday, October 6, 2009
Nexus DX Raises $15M
San Diego-based Nexus DX, a stealth mode, biotech firm, has raised $9.0M in a venture round, according to a regulatory filing from the firm this week. Details on the funding have not been announced. Kleiner Perkins Caufield & Byers as well ... READ MORE...
posted on Thursday, October 1, 2009
Life Technologies, Illumina In Patent Spat
San Diego-based Illumina said today that it has been served with a complaint alleging patent infringement, from Carlsbad-based Life Technologies. According to Illumina, it is being sued by Life Technologies, Applied Biosystems, a Russian re... READ MORE...
posted on Thursday, September 24, 2009
Zogenix Gets $51M In Series B
San Diego-based Zogenix, a pharmaceutical firm developing treatments for neuroscience disorders and pain, said Wednesday that it has completed a $51M, Series B preferred stock financing. The firm said that the round was led by Clarus Ventur... READ MORE...
posted on Wednesday, September 23, 2009
Gamma Medica-Ideas Raises $24M
Northridge-based Gamma Medica-Ideas, a developer of digital molecular imaging systems, said Tuesday that it has raised $24M in financing. The firm said the round, the first institutional funding for the firm, was made up of $14M in equity, ... READ MORE...
posted on Tuesday, September 22, 2009
Quality Systems Names COO, Director
Irvine-based Quality Systems, a provider of IT products for the healthcare market, reported this morning that it has appointed Philip N. Kaplan as the firm's Chief Operating Officer, and added Craig A. Barbarosh to its board. Kaplan was mos... READ MORE...
posted on Monday, September 21, 2009
Celladon Gains $21.8M
La Jolla-based Celladon, a developer of treatments for heart failure and other cardiovascular diseases, has raised $21.8M out of a $24.6M funding round, according to a filing from the firm today. Details on the new funding round were not di... READ MORE...
posted on Friday, September 11, 2009
ValenTx Raises $22M In Series B
Carpinteria-based ValenTx, a developer of medical devices for addressing morbid obesity, announced today that it has raised $22M in a Series B financing round. The round was led by SV Life Sciences, and also included Covidien Ventures, Sapi... READ MORE...
posted on Tuesday, September 8, 2009
Visiogen Acquired By Abbott For $400M
Irvine-based Visiogen, a developer of intraocular lens technology for treating cataract patients, is being acquired by Abbott in a deal worth $400M. According to Abbott, it will pay $400M in cash for VisioGen, whose intraocular lens technol... READ MORE...
posted on Wednesday, September 2, 2009
Mabvax Finds $500K
San Diego-based Mabvax Pharmaceuticals, which is developing vaccines and human antibodies targeted at treating cancer, has gained $500,000 out of a $4M funding round, according to a regulatory filing from the firm. Mabvax had previously rai... READ MORE...
posted on Wednesday, September 2, 2009
Life Technologies Sells JV For $450M
Carlsbad-based Life Technologies, a developer of biotechnology tools, announced this morning that it has entered into a definitive agreement to sell its ownership stake in its mass spectrometry joint venture, to Danaher for $450M. Danaher i... READ MORE...
posted on Wednesday, September 2, 2009
Animal Cell Therapies Scores $1.1M
San Diego-based Animal Cell Therapies, a biotech firm developing stem cell treatments for animals, has raised $1.1M in a funding round, according to a regulatory filing by the firm Monday. No details on the funding have been released. The f... READ MORE...
posted on Tuesday, September 1, 2009
Aubrey Gets $3.87M
Carlsbad-based Aubrey, a startup developing wound care products that promote wound healing and burn care, has raised $3.87M in a $6.0M venture round, according to a regulatory filing from the firm Monday. Details on the funding have not bee... READ MORE...
posted on Tuesday, September 1, 2009
Metabasis Therapeutics Loses CEO
San Diego-based Metabasis Therapeutics reported this morning that the firm's President, CEO, and Chief Scientific Officer, Mark Erion, is leaving the firm. According to Metabasis, Erion is leaving the firm for Merck, to become Vice Presiden... READ MORE...
posted on Tuesday, September 1, 2009
Medsphere Raises $12M
Carlsbad-based Medsphere Systems, a developer of electronic health record software, announced Monday afternoon that the firm has raised $12M in a financing round. The round came from Azure Capital Partners, Epic Ventures, Thomas Weisel Vent... READ MORE...
posted on Monday, August 31, 2009
ValenTX Raises $20.28M
Carpinteria-based ValenTX, a developer of treatments for obesity, has raised $20.28M in an equity funding round, according to a regulatory filing by the firm Thursday. Details on the funding have not been released by the company. ValenTx ha... READ MORE...
posted on Thursday, August 27, 2009
Ligand Buys Drug Development Firm
San Diego-based Ligand Pharmaceuticals reported Monday that it has acquired Connecticut-based Neurogen, a developer of small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders. Ligand said ... READ MORE...
posted on Monday, August 24, 2009
Medicinova Buys Avigen
San Diego-based MediciNova, a biotech firm developing small-molecule therapeutics, said Friday that it has reached an agreement with Alameda-based Avigen to merge with the firm. Medicinova said Avigen shareholders would receive either $1.24... READ MORE...
posted on Friday, August 21, 2009
Palkion Raises $2.5M
San Diego-based Palkion, a developer of oral drugs for treating anemia, has raised $2.5M in a funding round, according to a regulatory filing from the firm Monday. Details on the funding have not been released. The firm is backed by ProQues... READ MORE...
posted on Wednesday, August 19, 2009
Datrix Acquired By Medical Devices Firm
Escondido-based Datrix, a developer of portable devices for heart monitoring, has been acquired by medical devices firm IntriCon Corporation for approximately $2.5M. St. Paul, Minnesota-based IntriCon said the deal includes $1.225M in cash,... READ MORE...
posted on Friday, August 14, 2009
Domain Associates Raises $500M Venture Fund
Venture capital firm Domain Associates, which is based in San Diego and New Jersey, said Monday that it has closed a $500M fund focused on the life sciences industry. The firm said the fund, Domain Partners VIII, L.P., will continue to focu... READ MORE...
posted on Monday, August 10, 2009
ChemNavigator Acquired By Sigma-Aldrich
San Diego-based ChemNavigator, a developer of informatics tools for the pharmaceutical industry, has been acquired by scientific equipment firm Sigma-Aldrich. Financial terms of the buy were not disclosed. According to Sigma-Aldrich, the bu... READ MORE...
posted on Friday, August 7, 2009
Spectrum Pharmaceuticals Buys Remaining Rights To Compound
Irvine-based Spectrum Pharmaceuticals has acquired the remaining rights to RenaZorb, the firm's nanotechnology compound being used for treating hyperphosphatemia in patients with chronic kidney disease. The firm said it is paying $750,000 i... READ MORE...
posted on Thursday, August 6, 2009
Freedom Meditech Gets Additional Financing
San Diego-based Freedom Meditech, a developer of medical devices for measuring blood sugar in the diabetic, said today that it has raised a second tranche of funding in its Series A funding. Amount of the funding was not disclosed, however,... READ MORE...
posted on Tuesday, August 4, 2009
Celerus Diagnostics Ramps Automation Efforts
Carpinteria-based Celerus Diagnostics, a developer of scientific equipment for the pathology lab market, said today that it plans to introduce a totally automated immunohistochemistry (IHC) staining system to the market next year. The firm ... READ MORE...
posted on Monday, August 3, 2009
Beckman Coulter Buys Olympus' Diagnostics Business
Fullerton-based scientific equipment firm Beckman Coulter announced today that it has acquired the lab-based diagnostics business of Olympus, in a deal worth approximately 76 billion Japanese yen in cash, or approximately $780M. Beckman, wh... READ MORE...
posted on Monday, August 3, 2009
Cortex Pharmaceuticals Gets $2.0M In PIPE
Irvine-based Cortex Pharmaceuticals, which is developing treatments for sleep apnea, reported this morning that it has received $2.0M in a Series F, convertible preferred stock financing from an unnamed, single institutional investor. The f... READ MORE...
posted on Thursday, July 30, 2009
Replenish Raises $10.25M
Pasadena-based Replenish Inc. has quietly raised $10.25M in venture funding, according to a regulatory filing by the firm this week. No details on the firm have been disclosed, however, the firm describes itself as working on a "flexible dr... READ MORE...
posted on Wednesday, July 29, 2009
aTyr Pharma Gets $12M
San Diego-based aTyr Pharma, which is developing biopharmaceuticals focused on inflammation, autoimmune, hematopoietic and metabolic disorders, disclosed Tuesday that it has raised $12M in an additional funding round. The firm said the fund... READ MORE...
posted on Tuesday, July 28, 2009
Epic Sciences Raises $2.5M
San Diego-based Epic Sciences, a stealth mode startup which appears related to the Scripps Research Institute, has quietly raised $2.5M in a funding round. Epic is developing analytical laboratory instruments. The funding for the firm was d... READ MORE...
posted on Friday, July 24, 2009
Lithera Raises $10M
San Diego-based Lithera, which is developing injectable treatments for fat tissue reduction, has raised $10M in a funding round. Source of the funding was not announced by the firm. Lithera, which was formerly known as Lipothera, is backed ... READ MORE...
posted on Wednesday, July 22, 2009
BeneChill Pulls In $13.5M
San Diego's BeneChill, a firm developing medical devices for rapid, non-invasive cooling of patients for the treatment of cardiac arrest, stroke, or head injury, said Monday that it has raised $13.5M in a Series C financing round. The round... READ MORE...
posted on Monday, July 20, 2009
Numira Biosciences Gets $3.2M
Irvine-based Numira Biosciences, a contract research organization focused on high resolution imaging, has raised $3.2M in a funding round, according to a recent regulatory filing by the firm. No details on the funding have been announced by... READ MORE...
posted on Monday, July 20, 2009
StemCyte Gains $1M In Debt
Covina-based StemCyte, a venture-backed operator of an umbilical cord blood bank, has scored $1M in a debt funding round, according to debt financing firm Agility Capital. Agility said that the senior secured growth capital loan closed in J... READ MORE...
posted on Tuesday, July 14, 2009
DexCom Expands Board
San Diego-based DexCom, which develops continuous glucose monitoring systems for the hospital industry, said this week that it has named Eric Topol, M.D., to its board. Topol is the Director of the Scripps Translational Science Institute. D... READ MORE...
posted on Friday, July 10, 2009
USC Spinout Gains From $3.5M Award
A spinout of the University of Southern California, Pivotal Biosciences, is benefiting from the approval of a $3.5M drug development project that was just approved by the National Cancer Institute, for developing a treatment for metastatic... READ MORE...
posted on Thursday, July 9, 2009
Intellikine Raises $51M
La Jolla-based Intellikine, a developer of small molecule drugs for the treatment of cancer, inflammation, and autoimmune diseases, said Wednesday that it has raised $51M in a financing round for the firm. The round was led by Novartis Biov... READ MORE...
posted on Thursday, July 9, 2009
Pegasus Biologics Acquired By Synovis
Irvine-based Pegasus Biologics, a venture backed developer of collagen-based bioimplants for orthopedic, spine, and neurosurgery, has been acquired by Synovis Life Technologies, Inc. Synovis said that it has signed a definitive purchase agr... READ MORE...
posted on Tuesday, July 7, 2009
Somaxon Gets $6M In PIPE
San Diego-based Somaxon Pharmaceuticals reports today that the publicly held firm has received a $6M, private equity financing. The firm said that the funding came from its existing venture investors, including MPM Capital, Montreux Equity ... READ MORE...
posted on Tuesday, July 7, 2009
Life Technologies To Sell Business Unit
Carlsbad-based Life Technologies, a developer of biotechnology tools and products, reported today that it is selling its SQL*LIMS laboratory information management software business to LabVantage Solutions, Inc. Financial terms of the dives... READ MORE...
posted on Tuesday, June 30, 2009
Ambit Biosciences Gets $6.4M In Debt
San Diego-based Ambit Biosciences, a developer of small molecule profiling tools being used for biopharmaceuticals development, has raised $6.5M in an ongoing, debt round, according to a filing from the firm today. Details on the debt round... READ MORE...
posted on Monday, June 29, 2009
Sorrento Therapeutics Gets $2.3M
San Diego-based Sorrento Therapeutics, a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. The firm is headed by Antonius... READ MORE...
posted on Friday, June 19, 2009
Halozyme Therapeutics Names VP
San Diego-based Halozyme Therapeutics reported today that the firm has named H. Michael Shepard, Ph.D., as the firm's new Vice President of Discovery Research. According to Halozyme, Shepard was most recently at Receptor Biologix, where he ... READ MORE...
posted on Wednesday, June 17, 2009
Accelrys Names New CEO
San Diego-based life sciences and scientific software developer Accelrys reported Monday that Scipio "Max" Carnecchia has joined the company as chief executive officer and president, effective immediately. Carnecchia has also been appointed... READ MORE...
posted on Tuesday, June 16, 2009
Inovio Biomedical, Cardigant Medical In Licensing Deal
San Diego-based Inovio Biomedical and Long Beach-based Cardigant Medical announced this morning that the two firms are in a commercial license, where Cardigant Medical will use Inovio's technology to develop intravascular catheters. Financi... READ MORE...
posted on Monday, June 15, 2009
Protabit, Monsanto Launch Startup
Pasadena-based Protabit, a brand new startup based on research from Caltech, and chemical giant Monsanto disclosed this morning that the two firms have entered into a two-year collaboration, to develop new tools for protein design and optim... READ MORE...
posted on Thursday, June 11, 2009
Illumina Gets Into Personal Genome Sequencing
San Diego-based Illumina, which makes gene sequencing and other related life sciences equipment, said Wednesday afternoon that the firm is getting into the personal genome sequencing market. According to Illumina, it will offer complete cov... READ MORE...
posted on Wednesday, June 10, 2009
VivoMetrics Announces New LifeShirt
Ventura-based VivoMetrics, which develops patient monitoring devices, said this week that it has completed a prototype of the firm's next generation LifeShirt product, which is used for remote monitoring of patient vital signs. According to... READ MORE...
posted on Wednesday, June 10, 2009
Aperio Sues Olympus, Hamamatsu
Vista-based Aperio Technologies, which develops digital pathology products for the healthcare and life sciences industries, is reporting that it has filed a patent infringement lawsuit against Olympus America, Inc., Hamamatsu Corporation an... READ MORE...
posted on Wednesday, June 10, 2009
CardioDynamics Acquired For $10M
San Diego-based CardioDynamics, a maker of cardiography products used for non-invasive assessment of cardiac output, is being acquired for $10M by SonoSite. According to Sonosite, it will pay $1.35 per share in cash for publicly held Cardi... READ MORE...
posted on Tuesday, June 9, 2009
TrueVision Systems Adds $1.2M
Santa Barbara-based TrueVision Systems, a developer of 3D visualization technology used for microsurgery, said this week that it has raised $1.2M in a convertible financing round, part of an effort which will raise $2M for the firm. TrueVis... READ MORE...
posted on Tuesday, June 9, 2009
aFraxis Gets $750K
San Diego-based aFraxis, a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announce... READ MORE...
posted on Tuesday, June 9, 2009
Alphatec Spine Gains $10M In PIPE
Carlsbad-based Alphatec Holdings, the parent firm of medical device firm Alphatec Spine, announced Friday that the firm has raised $10M in a private placement. According to the company, the funding came from Healthpoint Capital Partners II,... READ MORE...
posted on Friday, June 5, 2009
Applied Biosystems Ships Mass Spectrometry Tools
Carlsbad-based Applied Biosystems announced Monday that the firm has shipped a number of new, mass spectrometry tools aimed at the laboratory market. According to the firm, which is a division of Life Technologies, the new tools are targete... READ MORE...
posted on Monday, June 1, 2009
Metabasis Therapeutics Lops 85 Percent , Looks For Buyer
San Diego-based Metabasis Therapeutics, which is developing treatments for metabolic diseases, said Wednesday that it will cut approximately 85 percent, or 45 of its employees. According to the firm, the move was necessary because of "diffi... READ MORE...
posted on Wednesday, May 27, 2009
Ophthonix Gains $25.9M In Series AA
Vista-based Ophthonix, which is developing high definition vision correction products, announced Tuesday afternoon that it has raised $25.9M in what it is calling a "Series AA" funding round. According to the firm, investors in the new roun... READ MORE...
posted on Tuesday, May 26, 2009
Spectrum Pharmaceuticals Wins $4.3M In Arbitration
Irvine-based biotechnology firm Spectrum Pharmaceuticals reports that it has won $4.3M in an arbitration over a dispute with Cell Therapeutics, over liabilities over joint venture expenses. According to the firm, $3.5M of the amount was ord... READ MORE...
posted on Tuesday, May 26, 2009
Abraxis Names VP
Los Angeles-based Abraxis BioScience, a biotech firm focused on treatments for cancer, said Friday that it has hired on Marty J. Duvall as the firm's Senior Vice President, Global Marketing and International Commercial Operations. Duvall jo... READ MORE...
posted on Friday, May 22, 2009
NeoMend Finds $2.7M
Irvine-based NeoMend, which is developing wound healing products, disclosed this week via a regulatory filing that it has raised $2.7M out of a $3.5M funding round for the company, consisting of a convertible note along with warrants conver... READ MORE...
posted on Thursday, May 21, 2009
Aragon Pharmaceuticals Gets $8M
La Jolla-based Aragon Pharmaceuticals reported Wednesday that it has raised $8M in a Series A financing. The firm, which is focused on small molecule therapeutics for treating hormone-resistant cancers, said that the financing was led by Th... READ MORE...
posted on Thursday, May 21, 2009
Victory Pharma Acquired By Sciele Pharma
San Diego-based specialty pharmaceuticals firm Victory Pharma has been acquired by Atlanta-based Sciele Pharma, Sciele said this week. According to Schiele, it will pay $150M to acquire Victory Pharma, which is focused on acquiring, develop... READ MORE...
posted on Wednesday, May 20, 2009
Metabasis Therapeutics Running Short On Runway, Looks For Capital
San Diego-based Metabasis Therapeutics, which develops biopharmaceuticals for treating metabolic diseases, said today as part of its quarterly results that it is hoping to raise capital in Q2 to fund the firm's operations. The firm--which s... READ MORE...
posted on Thursday, May 14, 2009
Anaphore Takes $13M
La Jolla-based Anaphore, a developer of protein therapeutics, announced today that it has raised an additional $13M in the firm's Series A preferred stock financing. According to the firm, the new funding brings the total round size to $38M... READ MORE...
posted on Thursday, May 14, 2009
Medsphere Hires New CFO
Carlsbad-based Medsphere Systems, a venture-backed developer of open source electronic health records software, said Friday that it has named Irv Lichtenwald as its Chief Financial Officer. Lichtenwald previously served as CFO For Advent So... READ MORE...
posted on Friday, May 8, 2009
Illumina Sues Affymetrix
San Diego-based Illumina, a developer of life sciences and genetic analysis systems, disclosed Tuesday that it has filed a patent infringement suit against competitor Affymetrix. According to Illumina, the suit--filed in the United States D... READ MORE...
posted on Tuesday, May 5, 2009
Visiogen Gains $40M In Funding
Irvine-based Visiogen is reporting this morning that it has raised $40M in a financing round for its intraocular lens technology. The firm said the funding was led by Novartis Venture Fund, and also included investments from Technology Part... READ MORE...
posted on Monday, April 27, 2009
InTouch Health Names VP
Santa Barbara-based InTouch Health, a developer of telepresence robots for the healthcare market, said this week that it has named Gerry Popolow as the firm's Vice President of Clinical Services and Account Management. Popolow has served as... READ MORE...
posted on Friday, April 24, 2009
X Prize Foundation Puts DNA Mapping Up For Bid On eBay
Playa Vista-based X Prize Foundation is taking an unusual approach to fund its nonprofit efforts, and is auctioning off a complete gene sequencing to the highest bidder on eBay. The auction--which starts at $68,000--will give the winner a c... READ MORE...
posted on Thursday, April 23, 2009
NuVasive Agrees to Acquire Cervitech for up to $80M
San Diego-based NuVasive, a manufacturer of products used in the surgical treatment of spine disorders, announced Wednesday that it has agreed to acquire Cervitech, a New Jersey-based firm developing a cervical disc replacement device. NuVa... READ MORE...
posted on Thursday, April 23, 2009
Abraxis Invests In Biotech Firm
Los Angeles-based Abraxis BioScience, a biotechnology firm focused on treatments for cancer and other illnesses, is the lead investor in a Maryland-firm developing technology for tissue protein analysis. According to Rockville, Maryland-bas... READ MORE...
posted on Tuesday, April 21, 2009
Vision Solutions Gains Medical Win
Irvine-based Vision Solutions reported yesterday that the firm has signed on healthcare provider The Jackson Clinic as a customer. Financial impact of the win was not disclosed. Vision Solutions said that The Jackson Clinic is using the fir... READ MORE...
posted on Friday, April 17, 2009
Obagi Medical Bails On Pharmacy Sales
Long Beach-based Obagi Medical Products, which develops aesthetic and therapeutic skin care products, said Monday afternoon that the firm will stop selling its SoluCLENZ Rx Gel in pharmacies. The firm said that the company will instead focu... READ MORE...
posted on Tuesday, April 14, 2009
TriZetto Signs Health Plan
Newport Beach-baed TriZetto Group, a developer of health care management software, said Monday that the firm has added the CareMore Health Plan as a customer. Financial impact of the deal was no disclosed. CareMore Health Plan is a provider... READ MORE...
posted on Monday, April 13, 2009
Invitrogen Releases Equipment
Carlsbad-based Invitrogen, a manufacturer of diagnostic equipment for the life sciences industry, announced this morning that it has released a new product. According to Invitrogen, its new GIBCO OPTmizer T-cell Expansion SFM is targeted at... READ MORE...
posted on Monday, April 13, 2009
X Prize Foundation To Set $10M Health Care Competition Rules
The X PRIZE Foundation, the Playa Vista-based nonprofit using multimillion dollar prizes to drive innovation, said Thursday that the firm will announce the initial prize parameters for its $10M+, Healthcare X PRIZE next week. According to t... READ MORE...
posted on Friday, April 10, 2009
La Jolla Pharmaceuticals Gets Dreaded "Going Concern" Opinion
San Diego-based La Jolla Pharmaceuticals, a publicly traded specialty pharmaceuticals firm, has received a dreaded "going concern" opinion from its auditor, Ernst & Young. The opinion--when an auditor decides that the firm being audited has... READ MORE...
posted on Thursday, April 9, 2009
Inovio Biomedical Adds Director
San Diego-based Inovio Biomedical Corporation said yesterday that the firm has appointd Ng Tee Khiang to the firm's board. Khiang is co-founder, partner, and director of a number of firms, including Evia Capital Partners Pte. Ltd. and Evia ... READ MORE...
posted on Tuesday, April 7, 2009
Cianna Medical Finds $10M
Aliso Viejo-based Cianna Medical is reporting today that the firm has completed a Series B funding round worth more than $10M. The firm, which is developing treatments for early stage breast cancer, said the funding comes from Emergent Medi... READ MORE...
posted on Tuesday, April 7, 2009
LensX Lasers Raises $22M
Aliso Viejo-based LensX Lasers, a maker of cataract surgery devices, has raised $22.36M in a funding round, according to a recent regulatory filing. According to the filing, the funding came on March 19th, and included investors Versant Ven... READ MORE...
posted on Thursday, April 2, 2009
Aspyra Reorganizes, Delays 10-K
Calabasas-based Asprya, a provider of clinical information management systems for the healthcare market, said today that it has reorganized its management team. According to the firm, Bruce Miller, Chief Technology Officer of the firm and o... READ MORE...
posted on Thursday, April 2, 2009
Traversa Therapeutics Lands $5M In Second Round
La Jolla-based Travera Therapeutics, which is developing biopharmaceuticals based on RNA interference (RNAi) technology, said Thursday that it has raised $5M in a Series B financing round. The round was led by Morningside Venture Investment... READ MORE...
posted on Thursday, April 2, 2009
TorreyPines Therapeutics Lops Employees, Looks For Buyer
La Jolla-based TorreyPines Therapeutics, a biopharmaceuticals firm focused on small molecule compounds, said this week that it has reduced its work force to just three employees. The firm said the move came as it looks to evaluate strategic... READ MORE...
posted on Thursday, April 2, 2009
Ambrx Gains $10M
La Jolla-based Ambrx, which is developing protein and antibody drugs, said in a regulatory filing today that it has raised $10M. No details of the funding round have been disclosed. Ambrx has previously raised capital from 5AM Ventures, Mav... READ MORE...
posted on Wednesday, April 1, 2009
Quidel Cuts 10 Percent
San Diego-based Quidel, a developer of diagnostic tests for the healthcare industry, said Tuesday that it has cut approximately 10 percent of its work force, or 31 employees, in a corporate restructuring. According to Quidel, it made the cu... READ MORE...
posted on Tuesday, March 31, 2009
Somaxon Gets Nasdaq Warning
San Diego-based Somaxon Pharmaceuticals, a specialty pharmaceuticals firm in the central nervous system therapeutic area, said Thursday afternoon that the firm has received a warning from the Nasdaq Stock Market. The warning--which is a pre... READ MORE...
posted on Thursday, March 26, 2009
Pure Bioscience In India Distribution Deal
San Dieog-based PURE Bioscience, a developer of an antimicrobial disinfectant, said Wednesday that it has licensed a distributor for its products in India. According to PURE Bioscience, the firm's products will be distributed under the bran... READ MORE...
posted on Wednesday, March 25, 2009
Adventrx Reaches End Of Line, Looks For Buyer
San Diego-based Adventrx Pharmaceuticals, which was developing pharmaceuticals to improve existing cancer treatments, said late Friday that it will discontinue "substantially all" of its development activities and business operations. The f... READ MORE...
posted on Monday, March 23, 2009
Relsys International Acquired By Oracle
Irvine-based Relsys International, a developer of drug safety and risk management software for the health care industry, has been acquired by software giant Oracle. Oracle said this morning that it has agreed to acquire Relsys, which will b... READ MORE...
posted on Monday, March 23, 2009
Advantar Laboratories In Deal With NextPharma
San Diego-based Advantar Laboratories, a provider of contract laboratory services to the drug development industry, has signed an agreement with UK-based firm NextPharma Technologies, a pharmaceutical product development, contract manufactu... READ MORE...
posted on Friday, March 20, 2009
Cortex Pharmaceuticals Lops Half Of Workers
Irvine-based Cortex Pharmaceuticals, a developer of biopharmaceuticals for treating psychiatric disorders, neurological diseases and brain-mediated breathing disorders, said Thursday that it has cut half of its staff as part of a restructur... READ MORE...
posted on Thursday, March 19, 2009
Innovative Micro Targets Life Sciences
Santa Barbara-based Innovative Micro Technology, a maker of micro-electromechanical (MEMS) systems, announced today that the firm has created a new division focused on life sciences. The firm said the new division will focus on developing m... READ MORE...
posted on Tuesday, March 17, 2009
InstaMed Gains $6M
InstaMed, which operates a network for healthcare payment processing, said Tuesday that the firm has raised $6M in a growth equity financing. The firm, which has operations in Newport Beach and is headquartered in Philadelphia, said the rou... READ MORE...
posted on Tuesday, March 17, 2009
Zynx Health Upgrades Software
Los Angeles-based Zynx Health, a developer of health care decision support software, said this morning that the firm has upgraded its AuthorSpace software. According to the firm, the new version of the software adds such features as PDF exp... READ MORE...
posted on Monday, March 16, 2009
NeoMatrix Gains $15M In Funding
Irvine-based NeoMatrix, a developer of a noninvasive breast cancer screening device, said Friday that it has completed a C2 funding round, worth $15M. Investors in the round were not disclosed. According to the firm, the round was oversubsc... READ MORE...
posted on Friday, March 13, 2009
Sangart Gets $50M
San Diego-based Sangart, a biopharmaceuticals firm focused on the commercialization of oxygen therapeutics, said Thursday that it has raised $50M in a Series F funding round. Names of investors were not disclosed, however, the firm said the... READ MORE...
posted on Friday, March 13, 2009
Fate Therapeutics Names Chief Scientific Officer
La Jolla-based Fate Therapeutics, a firm developing stem cell technology, said today that it has named Ken Batchelor, Ph.D., as the firm's Chief Scientific Officer. Batchelor joins the firm GlaxoSmithKline, where he was most recently Senior... READ MORE...
posted on Thursday, March 12, 2009
Victory Pharma Raises $45M
San Diego-based Victory Pharma has raised $45M in an equity financing round, the firm said Monday. The round was led by Essex Woodlands Health Ventures, and also included prior investor Ampersand Ventures. According to Victory Pharma, Scott... READ MORE...
posted on Monday, March 9, 2009
Regulus Therapeutics Raises $20M
Carlsbad-based Regulus Therapeutics, a biopharmaceuticals firm focused on microRNA-based therapeutics, announced this morning that it has raised $20M in a Series A funding round. The investment came from Alnylam Pharmaceuticals and Isis Pha... READ MORE...
posted on Wednesday, March 4, 2009
Xencor In License Deal With Pfizer
Monrovia, California-based Xencor, which is developing antibodies to treat such things as Hodgkin lymphoma and inflammatory disease, said this morning that it has inked a technology license and evaluation agreement with Pfizer. According to... READ MORE...
posted on Monday, March 2, 2009
Metabasis Names CFO
San Diego-based Metabasis Therapeutics has hired on a new Vice President and Chief Financial Officer, the firm disclosed today. Metabasis, which is developing biopharmaceuticals for treating metabolic and other diseases, said that it has na... READ MORE...
posted on Monday, March 2, 2009
Helixis Adds Illumina's Flatley To Board
Carlsbad-based Helixis, which develops tools for nucleic acid analysis, said Thursday that it has added Illumnia CEO Jay Flatley to the firm's board of directors. The company, which is venture backed by Domain Associates and Okapi Venture C... READ MORE...
posted on Friday, February 27, 2009
Xifin Hires CFO, Marketing VP
San Diego-based XIFIN, a publisher of hosted revenue cycle management software for diagnostic laboratories, reported Tuesday that it has added two members to its executive staff. The company said it has hired Steve Zaniboni as chief financi... READ MORE...
posted on Wednesday, February 25, 2009
CoreValve Acquired By Medtronic For $700M
Irvine-based CoreValve, a venture-backed developer of an aortic valve replacement market, has been acquired by Medtronic in a $700M deal, Medtronic said this morning. According to Medtronic, it will pay $700M plus additional contingent paym... READ MORE...
posted on Monday, February 23, 2009
La Jolla Pharmaceuticals Lays Off Staff, Looks To Sell Firm
San Diego-based La Jolla Pharmaceutical Company has laid of a "substantial" number of the firm's personnel, and is looking to either shut down the business or sell the company, the firm said Thursday, after a failure of the firm's Phase 3 t... READ MORE...
posted on Friday, February 20, 2009
Kythera Biopharmaceuticals Lands $10M
Los Angeles-based Kythera Biopharmaceuticals, which is developing products for the aesthetic medicine market, disclosed this morning that it has received $10M as part of the firm's Series C funding round. According to Kythera, the round inc... READ MORE...
posted on Wednesday, February 18, 2009
Cadence Pharmaceuticals Raises $86.6M In PIPE
San Diego-based Cadence Pharmaceuticals, which licenses, develops, and commercializes biopharmaceuticals, said Tuesday that it has reached an agreement to raise approximately $86.6M from a group of venture capital investors. The publicly he... READ MORE...
posted on Tuesday, February 17, 2009
Celerus Diagnostics Gets $5M
Carpinteria-based Celerus Diagnostics, which is developing products focused on providing rapid cancer diagnostics, announced today that it has raised $5M in a Series C funding round. Investors in the new round were not disclosed. According ... READ MORE...
posted on Thursday, February 12, 2009
Mpex Pharmaceuticals Gains $27.5M
San Diego-based Mpex Pharmaceuticals said Tuesday that the firm has raised $27.5M in a Series D financing round. The firm, which is developing antibiotics, said that the round was led by Investor Growth Capital. Other investors in the firm ... READ MORE...
posted on Tuesday, February 10, 2009
SynergEyes Sees $13.3M
Carlsbad-based SynergEyes, a developer of hybrid contact lenses, announced Friday that the firm has raised $13.3M in a Series C funding round. SynergEyes said that the round was led by De Novo Ventures, and also included Bio-Star Private Eq... READ MORE...
posted on Friday, February 6, 2009
Hollis-Eden Pharmaceuticals Lops A Third Of Company
San Diego-based Hollis-Eden Pharamceuticals, a developer of biopharmaceuticals, said Monday that the firm is cutting its workforce by approximately 33 percent, or 20 employees. According to the firm, the "aggressive" cost cutting plan is du... READ MORE...
posted on Monday, February 2, 2009
Aquea Scientific Gets $10.95M
Ventura-based Aquea Scientific, which develops a UVA/UVB sunscreen which can be washed on or applied in the shower, has quietly raised $10.955M in funding. The funding was first disclosed in the PricewaterhouseCOopers/NVCA MoneyTree venture... READ MORE...
posted on Thursday, January 29, 2009
Sequenom Buys SensiGen
San Diego-based Sequenom, a developer of genetic analysis products, said Monday afternoon that it has acquired SensiGen LLC, a biotechnology firm based in Ann Arbor, Michigan. Sequenom said it paid $8.7M for SensiGen, including earn-out mil... READ MORE...
posted on Monday, January 26, 2009
Axikin Pharmaceuticals Gets $3M
San Diego-based Axikin Pharmaceuticals, a new startup focused on small molecule therapeutics for respiratory and inflammatory disease, announced Thursday that it has raised $3M in a Series A funding. The company, which is a spinout of Actim... READ MORE...
posted on Thursday, January 22, 2009
Nanogen Looks For New Suitor
San Diego-based Nanogen, a developer of molecular diagnostics products, said today that it has received permission to investigate alternatives to a previously announced merger with the Elitech Group. Nanogen had originally announced its mer... READ MORE...
posted on Wednesday, January 21, 2009
Metabasis Therapeutics Lops 43 Percent
San Diego-based Metabasis Therapeutics, a biopharmaceuticals development firm, just announced this morning that it is cutting 38 employees, or approximately 43 percent of its employees as part of a corporate restructuring. Metabasis said th... READ MORE...
posted on Tuesday, January 20, 2009
Abraxis Bioscience Spins Out Personalized Medicine Firm
Los Angeles-based Abraxis Biosciences disclosed this morning that the firm's board has approved a plan to create a new company, Abraxis Health, Inc., which will focus on biomarkers and personalized medicine. According to Abraxis, the new fi... READ MORE...
posted on Tuesday, January 20, 2009
Sequenom In Hostile Bid For Competitor
San Diego-based Sequenom, a developer of genetic analysis products, is making a hostile bid for a competitor, EXACT Sciences Corporation, shortly after an offer was rejected by Exact's board. Sequenom said this morning that it has offered ... READ MORE...
posted on Wednesday, January 14, 2009
Ablation Frontiers Acquired By Medtronic
Carlsbad-based Ablation Frontiers, a venture-backed provider of products for the treatment of atrial fibrillation, has been acquired by Medtronic for $225M. According to Medtronic, it will pay $225M plus additional, unspecified contingent p... READ MORE...
posted on Monday, January 12, 2009
Illumina Signs University Customer
San Diego-based Illumina, a developer of life science analysis tools, said Monday that the firm's products have been selected by Duke University Medical Center. According to Illumina, researchers at the school will use its Genome Analyzer t... READ MORE...
posted on Monday, January 12, 2009
Anaphore Takes $25M In Series A
La Jolla-based Anaphore has raised $25M in a Series A financing, the firm said Wednesday, in a funding led by 5AM Ventures, Versant Ventures, and Apposite Capital. The firm, which is developing biopharmaceuticals for treating immune-mediate... READ MORE...
posted on Wednesday, January 7, 2009
OrthAlign Raises $7.2M
Laguna Beach-based OrthAlign said Wednesday that the firm has raised $7.2M in a Series A funding round, in what looks to be the first announced Southern California venture deal in 2009. The funding was led by Research Corporation Technologi... READ MORE...
posted on Wednesday, January 7, 2009
Illumina Hires Operations VP
San Diego-based Illumina has hired on a new Senior Vice President of Operations, Bill Bonnar, the firm disclosed this morning. The firm, which develops life science products and services for the genomics market, said that Bonnar joins the c... READ MORE...
posted on Monday, January 5, 2009
Dexcom Hires Executive
San Diego-based DexCom has appointed a new Chief Administrative Officer, the firm disclosed this morning, saying it had hired Steven R. Pacelli. The firm, which designs glucose monitoring systems for the healthcare industry, said that Pacel... READ MORE...
posted on Tuesday, December 16, 2008
Healthshoppr Launches Health Booking Site
Los Angeles-based Healthshoppr, a startup developing an online appointment booking and ratings site for the healthcare market, launched its beta site Thursday. The site has launched starting with the wellness market, offering bookings of ma... READ MORE...
posted on Friday, December 12, 2008
Medsphere In Education Deal
Carlsbad-based Medsphere is behind a new effort to help medical students learn about healthcare IT and clinical informatics, the firm disclosed this morning, and is supplying its products to the University of Oklahoma College of Nursing. Me... READ MORE...
posted on Tuesday, December 9, 2008
BioIQ Gets Win At Alere
Santa Barbara-based BioIQ, a provider of web-based, consumer health testing services, said last week that it has inked a deal to provide its services to Alere, a provider of health and wellness serviecs. According to BioIQ, the firms will w... READ MORE...
posted on Monday, December 8, 2008
Vical Cuts 20 Percent
San Diego-based Vical Incorporated, a biopharmaceuticals firm focused on immunotherapeutics for cancer and DNA vaccines for infectious diseases, said Friday that it has cut 29 employees, or approximately 20 percent of the firm. According to... READ MORE...
posted on Tuesday, November 25, 2008
Awarepoint Raises $13.3M
San Diego-based Awarepoint, a developer of systems for tracking assets and patients in hospitals, has raised $13.3M in a Series D funding. The firm said the round was led by Cardinal partners, and also included Venrock and prior investor Av... READ MORE...
posted on Tuesday, November 25, 2008
Abraxis BioScience Buys Back Rights
Los Angeles-based Abraxis BioScience, a biotechnology firm focused on compounds for treating cancer, said this morning that it has reached an agreement with AstraZeneca UK Limited to re-acquire rights to market the firm's ABRAXANE treatment... READ MORE...
posted on Tuesday, November 25, 2008
Aspyra Names CEO
Calabasas-based Aspyra, a provider of clinical information systems for the healthcare industry, has appointed Rodney Schutt as the firm's CEO. Schutt joins Aspyra from Luminetx, where he was Chief Operating Officer. Schutt has also served a... READ MORE...
posted on Friday, November 21, 2008
Zacharon Pharmaceuticals Raises $3.5M
San Diego-based Zacharon Pharmaceutical said today that it has raised $3.5M in a Series A financing for the firm's biopharmaceuticals technology. According to the firm, the financing came from Avalon Ventures LLC. The firm also said it has ... READ MORE...
posted on Tuesday, November 18, 2008
Valeant Pharmaceuticals Buys Australian Firm
Aliso Viejo-based Valeant Pharmaceuticals said today that it has acquired an Australian specialty pharmaceuticals firm, DermaTech Pty Ltd. Valeant said it paid approximately AU$19M ($12.5M US) for DermaTech, which develops products for the ... READ MORE...
posted on Friday, November 14, 2008
Ardea Biosciences Gets $8M Loan
San Diego-based Ardea Biosciences, which is developing small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases, announced Thursday that the firm has scored an $8M growth capital loan from Oxford Finance ... READ MORE...
posted on Thursday, November 13, 2008
CODA Genomics Becomes Verdezyne
Laguna Hills-based CODA Genomics, which is developing technology for engineering proteins, metabolic pathways and microorganisms for the life sciences, chemical, and biofuels market, said Tuesday that it is renaming itself Verdezyne, Inc. T... READ MORE...
posted on Tuesday, November 11, 2008
Precision Dynamics Buys TimeMed Labeling Systems
San Fernando-based Precision Dynamics Corporation, a provider of identification and labeling products for the hospital and healthcare market, has acquired TimeMed Labeling Systems, which creates specialty healthcare labels, the firms said T... READ MORE...
posted on Wednesday, November 5, 2008
Pegasus Biologics Names VP
Irvine-based Pegasus Biologics, which develops products for the soft tissue repair and wound care management market, said earlier this week that it has named Rob Cripe as its Vice President of Marketing and Product Development. Cripe joins ... READ MORE...
posted on Friday, October 31, 2008
Phenomix Gets $75M In Deal With Forest Labs
San Diego-based biopharmaceuticals firm Phenomix will receive $75M in an upfront payment, and up to $340M total, in a deal with Forest Laboratories, Inc., the firms said Thursday. According to the companies, they are in a definitive collabo... READ MORE...
posted on Friday, October 24, 2008
NaviMedix Acquires TopLine Solutions
San Diego-based NaviMedix said earlier this week that it has acquired TopLine Solutions, a provider of healthcare payment and collection services. Financial terms of the acquisition were not disclosed. NaviMedix operates a web-based network... READ MORE...
posted on Friday, October 24, 2008
Phenomix Drops IPO Bid
San Diego-based Phenomix Corporation, a biopharmaceuticals firm focused on small molecule drugs, has dropped its IPO bid, according to a filing by the company with the SEC this morning. Phenomix said that it has applied to withdraw its IPO,... READ MORE...
posted on Thursday, October 23, 2008
Vivometrics Gets $19.9M
Ventura-based Vivometrics, maker of medical monitoring technology, has raised $19.917M in funding, according to numbers released by this week's PricewaterhouseCoopers/NVCA venture capital report. Details of the funding were not disclosed. V... READ MORE...
posted on Tuesday, October 21, 2008
SkinMedica Scores Debt Financing
Carlsbad-based SkinMedica, a developer of cosmeceuticals for the dermatology field, has scored $27.5M in debt from two lenders. According to GE Healthcare Financial Services and BlueCrest Capital Finance, they have provided $27.5M in a seni... READ MORE...
posted on Tuesday, October 21, 2008
X Prize Foundation Targets Tuberculosis, Gets Gates Grant
The X Prize Foundation announced Thursday that it has received a grant from the Bill & Melinda Gates Foundation to develop a prize focused on the effective diagnosis of tuberculosis in the developing world. Amount of the grant was not discl... READ MORE...
posted on Friday, October 17, 2008
Cytori Gets $15M Loan
San Diego-based Cytori Therapeutics disclosed earlier this week that it has scored a $15M loan facility from GE Healthcare Financial Services and Silicon Valley Bank. The firm, which develops products for the regenerative medicine market, s... READ MORE...
posted on Friday, October 17, 2008
Valeant Pharmaceuticals Completes Coria Laboratories Buy
Aliso Viejo-based Valeant Pharmaceuticals International said Thursday that it has completed its acquisition of Coria Laboratories Ltd. The deal was worth $95M. Valeant had originally announced the acquisition of Coria Laboratories from its ... READ MORE...
posted on Thursday, October 16, 2008
Endologix Gets Unsolicited Offer To Buy Firm
Irvine-based Endologix, which develops medical devices for the minimally invasive treatment of abdominal aortic aneurysms, said Wednesday that it has received an unsolicited offer for the company from private equity firm Elliot Associates. ... READ MORE...
posted on Wednesday, October 15, 2008
CoreValve Expands Board
CoreValve Inc., a designer and manufacturer of artificial replacement components for the human heart, reported earlier this week that it has appointed Frank Fischer to its board of directors. The Irvine, Calif.-based company described Fisch... READ MORE...
posted on Friday, October 10, 2008
AMO Cuts Estimates, Blames Economy
Santa Ana-based Advanced Medical Optics is seeing an impact on it sales due to the economy, the firm disclosed this morning, saying it would lower its 2008 revenue guidance and EPS. According to AMO, it is now forecasting $1.17 billion to $... READ MORE...
posted on Thursday, October 9, 2008
Nexeon MedSystems Gets $24M
Nexeon MedSystems, a newly formed company focused on developing stents and other medical devices, announced this morning that the firm has raised $24M in funding from SurModics, Inc., Guidant Corporation, and other private investors. The fi... READ MORE...
posted on Tuesday, October 7, 2008
AMO Gets Approval On Medical Device
Santa Ana-based Advanced Medical Optics said this morning that it has received FDA approval on a medical device for opthalmic surgery. According to AMO, the U.S. Food and Drug Administration has granted premarket approval to the firm's Heal... READ MORE...
posted on Tuesday, October 7, 2008
Ligand Acquires Pharmacopeia
San Diego-based pharmaceuticals firm Ligand Pharmaceuticals said Thursday morning that it has entered into a definitive merger agreement to acquire Pharmacopeia. The deal is worth $70M. According to the firm, the deal is a stock-for-stock e... READ MORE...
posted on Thursday, September 25, 2008
Sequenom Acquires Diagnostics Lab
San Diego-based Sequenom, a provider of genetic analysis products, said Tuesday that it has agreed to acquire the Center for Molecular Medicine (CMM), a clinical diagnostics laboratory based in Grand Rapids, Michigan. According to Sequenom,... READ MORE...
posted on Tuesday, September 23, 2008
Tech Coast Angels Invests In Biopharmaceuticals Firm
The Tech Coast Angels said this morning that the group has made an investment in Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs. According to the Tech Coast Angels, it invested $289,000 in a Series A round f... READ MORE...
posted on Monday, September 22, 2008
Freedom Meditech Gets Investment
Freedom Meditech, a firm developing proprietary non-invasive ocular glucose measurement device for people with diabetes, has scored $380,000 in a equity investment. The round was disclosed by JumpStartup, an early stage venture acceleration... READ MORE...
posted on Monday, September 22, 2008
Endologix Hires VP
Irvine-based Endologix, which develops medical devices for the minimally invasive treatment of aneurysms, said this morning that it has hired Gary I. Sorsher as the firm's Vice President of Quality. According to Endologix, Sorsher joins the... READ MORE...
posted on Monday, September 22, 2008
Sofinnova Ventures Hires EIR In San Diego
Venture capital firm Sofinnova Ventures has hired on an Executive-in-Residence based in San Diego, the firm said Thursday. Sofinnova, which invests in early stage life sciences and IT firms, said it has appointed Lars Ekman, M.D., Ph.D. to ... READ MORE...
posted on Friday, September 19, 2008
Microfabrica Scores $22.5M
Van Nuys-based Microfabrica, which micro-fabricates three dimensional micro-devices, said Thursday that the firm has raised $22.5M in a Series B funding. The round was co-led by Versant Ventures and Interwest Partners, and also included pri... READ MORE...
posted on Thursday, September 4, 2008
BioIQ Rolls Out Wellness Testing Enhancements
Santa Barbara-based BioIQ, a startup providing web-linked health testing services, said this week that it has rolled out a new product targeted at corporate wellness testing. According to the firm, it has rolled out a new generation of the ... READ MORE...
posted on Thursday, August 28, 2008
Ivera Snags License From Becton Dickinson
San Diego-based medical device firm Ivera Medical Corporation has snagged a patent license from Becton, Dickenson and Company, the firm said this morning. Ivera announced that it is in an exclusive license agreement with BD, for the worldwi... READ MORE...
posted on Tuesday, August 26, 2008
Interview with Brent Reinke, Gold Coast Bio Center
Last week, the organizers behind the Gold Coast Bio Center, a life sciences incubator forming along the 101 technology corridor, held a meeting to talk about the group's efforts to tap into the wealth of experience in the area in the biotec... READ MORE...
posted on Thursday, August 14, 2008
Somaxon Pharmaceuticals Appoints CEO
San Diego-based Somaxon Pharmaceuticals said today that it has appointed Richard W. Pascoe as the firm's President and CEO. Pascoe will also serve as a director of the company. Pascoe was most recently at ARAID Pharmaceuticals, where he was... READ MORE...
posted on Thursday, August 7, 2008
Valeant Sells European Operations
Aliso Viejo-based Valeant Pharmaceuticals International, which develops specialty pharmaceuticals, said Monday that it has agreed to sell the firm's business operations in Western Europe and Eastern Europe, including Russia. The firm said t... READ MORE...
posted on Tuesday, August 5, 2008
Versant Ventures Closes Fourth Fund, Worth $500M
Versant Ventures, a Newport Beach- and Menlo Park-based venture capital fund, announced today that it has closed Versant Venture Capital IV, L.P. at $500M. The fund brings Versant's total under management to $1.6 billion, in the areas of bi... READ MORE...
posted on Thursday, July 31, 2008
Biologics Process Development Acquired By Indian Firm
Poway-based Biologics Process Development Incorporated, a provider of contract laboratory services for the biotechnology industry, has been acquired by an Indian biopharmaceuticals firm, Intas Biopharmaceuticals Ltd. According to the firms,... READ MORE...
posted on Friday, June 20, 2008